Xos (XOS) 10-Q/A 8 Mar 23 2022 Q2 Quarterly report (amended) Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 08, 2022
Entity Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-39598
Entity Registrant Name	XOS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-1550505
Entity Address, Address Line One	3550 Tyburn Street
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90065
City Area Code	818
Local Phone Number	316-1890
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		166,092,078
Amendment Flag	true
Entity Central Index Key	0001819493
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Description	Xos, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Form 10-Q/A”) to restate its unaudited condensed consolidated financial statements as of June 30, 2022, and for the three and six months ended June 30, 2022, previously included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 filed with the Securities and Exchange Commission (the “SEC”) on August 11, 2022 (the “Original Report”). This Form 10-Q/A also amends certain other items in the Original Report, as listed in “Items Amended in this Form 10-Q/A” below.
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	XOS
Security Exchange Name	NASDAQ
Warrant
Entity Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	XOSWW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 4,251	$ 16,142
Restricted cash	3,034	3,034
Accounts receivable	12,931	3,353
Marketable debt securities, available-for-sale — short-term	64,651	94,696
Inventories	58,242	30,883
Prepaid expenses and other current assets	17,798	17,850
Total current assets	160,907	165,958
Marketable debt securities, available-for-sale — long-term	13,218	54,816
Property and equipment, net	16,754	7,426
Operating lease right-of-use assets, net	7,306	0
Other non-current assets	1,504	506
Total assets	199,689	228,706
Liabilities
Accounts payable	8,419	10,122
Other current liabilities	18,004	5,861
Total current liabilities	26,423	15,983
Earn-out shares liability	11,894	29,240
Common stock warrant liability	4,227	7,496
Other non-current liabilities	10,738	1,594
Total liabilities	53,282	54,313
Commitments and Contingencies (Note 13)
Stockholders’ Equity
Common Stock $0.0001 par value, authorized 1,000,000 shares, 165,504 and 163,137 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	17	16
Preferred Stock $0.0001 par value, authorized 10,000 shares, 0 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	0	0
Additional paid-in capital	185,516	178,851
Accumulated deficit	(37,769)	(4,093)
Accumulated other comprehensive loss	(1,357)	(381)
Total stockholders’ equity	146,407	174,393
Total liabilities and stockholders’ equity	$ 199,689	$ 228,706

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	165,504,000	163,137,000
Common stock outstanding (in shares)	165,504,000	163,137,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenues	$ 9,766	$ 596	$ 16,797	$ 1,389
Cost of goods sold	15,070	585	28,100	1,257
Gross (loss) margin	(5,304)	11	(11,303)	132
Operating expenses
General and administrative	12,093	4,599	23,415	6,953
Research and development	7,635	2,742	14,584	5,741
Sales and marketing	2,960	524	4,988	836
Total operating expenses	22,688	7,865	42,987	13,530
Loss from operations	(27,992)	(7,854)	(54,290)	(13,398)
Other income (expense), net	(226)	126	(145)	(91)
Change in fair value of derivative instruments	3,703	(1,430)	3,268	4,964
Change in fair value of earn-out shares liability	14,870	0	17,494	0
Write off of subscription receivable	0	0	0	(379)
Realized loss on debt extinguishment	0	0	0	(14,104)
Loss before provision for income taxes	(9,645)	(9,158)	(33,673)	(23,008)
Provision for income taxes	1	0	3	0
Net loss	(9,646)	(9,158)	(33,676)	(23,008)
Marketable debt securities, available-for-sale
Change in net unrealized loss, net of tax of $0, for the three and six months ended June 30, 2022 and 2021	(150)	0	(976)	0
Total comprehensive loss	$ (9,796)	$ (9,158)	$ (34,652)	$ (23,008)
Net loss per share
Net loss per share — basic (in dollar per share)	$ (0.06)	$ (0.13)	$ (0.21)	$ (0.32)
Net loss per share — diluted (in dollar per share)	$ (0.06)	$ (0.13)	$ (0.21)	$ (0.32)
Weighted average shares outstanding
Weighted average shares outstanding — basic (in shares)	164,041	72,389	163,606	72,372
Weighted average shares outstanding — diluted (in shares)	164,041	72,389	163,606	72,372

Condensed Consolidated Statemen

Condensed Consolidated Statements of Legacy Xos Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit (As restated)	Accumulated Other Comprehensive Loss
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	2,762,000
Temporary equity, beginning balance at Dec. 31, 2020	$ 7,862
Increase (Decrease) in Temporary Equity [Roll Forward]
Payment of subscription receivable	$ 2,430
Issuance of preferred shares (in shares)	49,518,000
Issuance of Legacy Xos Preferred Stock, including note conversion	$ 66,701
Temporary equity, ending balance (in shares) at Mar. 31, 2021	52,280,000
Temporary equity, ending balance at Mar. 31, 2021	$ 76,993
Beginning balance (in shares) at Dec. 31, 2020		72,277,000
Beginning balance at Dec. 31, 2020	(27,197)	$ 7	$ 290	$ (27,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Payment of subscription receivable	380		380
Stock options exercised (in shares)		206,000
Stock options exercised	3		3
Shares repurchased and retired (in shares)		(94,000)
Stock repurchased and retired	(1)		(1)
Stock based compensation expense	2		2
Net loss	(13,850)			(13,850)
Ending balance (in shares) at Mar. 31, 2021		72,389,000
Ending balance at Mar. 31, 2021	$ (40,663)	$ 7	674	(41,344)	$ 0
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	2,762,000
Temporary equity, beginning balance at Dec. 31, 2020	$ 7,862
Temporary equity, ending balance (in shares) at Jun. 30, 2021	52,280,000
Temporary equity, ending balance at Jun. 30, 2021	$ 76,993
Beginning balance (in shares) at Dec. 31, 2020		72,277,000
Beginning balance at Dec. 31, 2020	(27,197)	$ 7	290	(27,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,008)
Net and comprehensive loss	(23,008)
Ending balance (in shares) at Jun. 30, 2021		72,391,000
Ending balance at Jun. 30, 2021	$ (49,820)	$ 7	675	(50,502)	0
Temporary equity, beginning balance (in shares) at Mar. 31, 2021	52,280,000
Temporary equity, beginning balance at Mar. 31, 2021	$ 76,993
Temporary equity, ending balance (in shares) at Jun. 30, 2021	52,280,000
Temporary equity, ending balance at Jun. 30, 2021	$ 76,993
Beginning balance (in shares) at Mar. 31, 2021		72,389,000
Beginning balance at Mar. 31, 2021	(40,663)	$ 7	674	(41,344)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)		2,000
Stock based compensation expense	1		1
Net loss	(9,158)			(9,158)
Net and comprehensive loss	(9,158)
Ending balance (in shares) at Jun. 30, 2021		72,391,000
Ending balance at Jun. 30, 2021	$ (49,820)	$ 7	675	(50,502)	0
Temporary equity, beginning balance (in shares) at Dec. 31, 2021	0
Temporary equity, beginning balance at Dec. 31, 2021	$ 0
Temporary equity, ending balance (in shares) at Mar. 31, 2022	0
Temporary equity, ending balance at Mar. 31, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	163,137,000	163,137,000
Beginning balance at Dec. 31, 2021	$ 174,393	$ 16	178,851	(4,093)	(381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	400,000
Stock based compensation expense	$ 1,068		1,068
Issuance of common stock for vesting of restricted stock units (in shares)		133,000
Shares withheld related to net share settlement of stock-based awards (in shares)		(36,000)
Shares withheld related to net share settlement of stock-based awards	(97)		(97)
Issuance of common stock for commitment shares under Standby Equity Purchase Agreement (in shares)		19,000
Issuance of common stock for commitment shares under the Standby Equity Purchase Agreement	62		62
Net and comprehensive loss	(24,856)			(24,030)	(826)
Ending balance (in shares) at Mar. 31, 2022		163,253,000
Ending balance at Mar. 31, 2022	$ 150,570	$ 16	179,884	(28,123)	(1,207)
Temporary equity, beginning balance (in shares) at Dec. 31, 2021	0
Temporary equity, beginning balance at Dec. 31, 2021	$ 0
Temporary equity, ending balance (in shares) at Jun. 30, 2022	0
Temporary equity, ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	163,137,000	163,137,000
Beginning balance at Dec. 31, 2021	$ 174,393	$ 16	178,851	(4,093)	(381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(33,676)
Net and comprehensive loss	$ (34,652)
Ending balance (in shares) at Jun. 30, 2022	165,504,000	165,504,000
Ending balance at Jun. 30, 2022	$ 146,407	$ 17	185,516	(37,769)	(1,357)
Temporary equity, beginning balance (in shares) at Mar. 31, 2022	0
Temporary equity, beginning balance at Mar. 31, 2022	$ 0
Temporary equity, ending balance (in shares) at Jun. 30, 2022	0
Temporary equity, ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Mar. 31, 2022		163,253,000
Beginning balance at Mar. 31, 2022	$ 150,570	$ 16	179,884	(28,123)	(1,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	38,693,000	385,000
Stock options exercised	$ 1		1
Stock based compensation expense	1,407		1,407
Issuance of common stock for vesting of restricted stock units (in shares)		89,000
Shares withheld related to net share settlement of stock-based awards (in shares)		(33,000)
Shares withheld related to net share settlement of stock-based awards	(86)		(86)
Issuance of common stock for commitment shares under Standby Equity Purchase Agreement (in shares)		1,810,000
Issuance of common stock for commitment shares under the Standby Equity Purchase Agreement	4,311	$ 1	4,310
Net loss	(9,646)
Net and comprehensive loss	$ (9,796)			(9,646)	(150)
Ending balance (in shares) at Jun. 30, 2022	165,504,000	165,504,000
Ending balance at Jun. 30, 2022	$ 146,407	$ 17	$ 185,516	$ (37,769)	$ (1,357)

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
OPERATING ACTIVITIES:
Net loss	$ (9,646)	$ (9,158)	$ (33,676)	$ (23,008)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	300	300	562	380
Amortization of right-of-use assets			815	0
Inventory reserve			1,991	0
Write off of subscription receivable	0	0	0	379
Realized loss on debt extinguishment	0	0	0	14,104
Change in fair value of derivative instruments	(3,703)	1,430	(3,268)	(4,964)
Change in fair value of earn-out shares liability	(14,870)	0	(17,494)	0
Net realized losses on marketable debt securities, available-for-sale			69	0
Stock-based compensation expense			2,469	3
Other non-cash items			1,191	0
Changes in operating assets and liabilities:
Accounts receivable			(9,578)	(392)
Inventories			(28,882)	(4,941)
Prepaid expenses and other current assets			52	(1,697)
Other assets			(998)	0
Accounts payable			(2,445)	(581)
Other liabilities			13,364	564
Net cash used in operating activities			(75,828)	(20,153)
INVESTING ACTIVITIES:
Purchase of property and equipment			(9,462)	(702)
Proceeds from sales and maturities of marketable debt securities, available-for-sale			69,561	0
Net cash provided by (used in) investing activities			60,099	(702)
FINANCING ACTIVITIES:
Proceeds from issuance of shares of Legacy Xos Preferred Stock			0	31,757
Proceeds from subscription receivable – preferred			0	2,430
Principal payment of equipment leases			(289)	(77)
Taxes paid related to net share settlement of stock-based awards			(183)	0
Proceeds from stock option exercises			0	3
Proceeds from issuance of common stock under Standby Equity Purchase Agreement			4,310	0
Net cash provided by financing activities			3,838	34,113
Net (decrease) increase in cash, cash equivalents and restricted cash			(11,891)	13,258
Cash, cash equivalents and restricted cash, beginning of period			19,176	10,359
Cash, cash equivalents and restricted cash, end of period	7,285	23,617	7,285	23,617
Reconciliation of Cash, Cash Equivalents and Restricted Cash to Unaudited Condensed Consolidated Balance Sheets:
Cash and cash equivalents	4,251	23,617	4,251	23,617
Restricted cash	3,034	0	3,034	0
Total cash, cash equivalents and restricted cash	$ 7,285	$ 23,617	7,285	23,617
Supplemental disclosure of non-cash investing and financing activities
Purchase of property and equipment in accounts payable			741	0
ROU assets obtained in exchange for operating lease obligations			437	0
Conversion of notes payable to Legacy Xos Preferred Stock:
Issuance of redeemable convertible preferred stock			0	34,918
Issuance of Legacy Xos Preferred Stock, including note conversion			0	2,453
Conversion of notes payable into preferred stock			0	21,540
Fair value adjustment of related party debt at conversion			$ 0	$ 3,763

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Change in net unrealized loss, tax	$ 0	$ 0	$ 0	$ 0

Description of Business

Description of Business	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business Xos, Inc. and its wholly owned subsidiaries (collectively, the “Company” or “Xos”) is a mobility solutions company. Xos manufactures Class 5 to 8 battery-electric commercial vehicles, facilitates fleet transition from traditional internal combustion engine vehicles to electric vehicles, and enables electric fleets to better manage their fleet operations through a portfolio of management tools. Xos developed the X-Platform (its proprietary, purpose-built vehicle chassis platform) and the X-Pack (its proprietary battery system) specifically for the medium- and heavy-duty commercial vehicle segment with a focus on last-mile commercial fleet operations. Xos’ “Fleet-as-a-Service” package offers customers a comprehensive suite of commercial products and services to facilitate electric fleet operations and seamlessly transition their traditional combustion-engine fleets to battery-electric vehicles. Xos Fleet, Inc. (“Legacy Xos”), the new legal entity name of the legacy Xos operating entity and Xos Services, Inc. (“Xos Services”, formerly Rivordak, Inc.), the subsidiary holding a California dealer license to sell Xos vehicles, are wholly owned subsidiaries of Xos, Inc., and make up 100% of the operations of the Company. Business Combination Xos, Inc. was initially incorporated on July 29, 2020 as a Cayman Islands exempted company under the name “NextGen Acquisition Corporation” (“NextGen”). On August 20, 2021, the transactions contemplated by the Agreement and Plan of Merger, as amended on May 14, 2021, by and among NextGen, Sky Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of NextGen (“Merger Sub”), and Xos, Inc., a Delaware corporation (now known as Xos Fleet, Inc., “Legacy Xos”), were consummated (the “Closing”), whereby Merger Sub merged with and into Legacy Xos, the separate corporate existence of Merger Sub ceased and Legacy Xos became the surviving corporation and a wholly owned subsidiary of NextGen (such transaction the “Merger” and, collectively with the Domestication, the “Business Combination”). As a result, Xos became the publicly traded entity listed on the Nasdaq Global Market. Emerging Growth Company Section 102(b)(1) of the Jumpstart its Business Startups Act (“JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement declared effective pursuant to the Securities Act of 1933, as amended (the “Securities Act”), or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard, until such time the Company is no longer considered to be an emerging growth company. At times, the Company may elect to early adopt a new or revised standard. Risks and Uncertainties COVID-19 and actions taken to mitigate its spread have had and may continue to have an adverse impact on the economies and financial markets of many countries, including the areas in which the Company operates. As the COVID-19 pandemic continues to evolve, the Company believes the extent of the pandemic’s impact to its business, operating results, cash flows, liquidity and financial condition will be primarily driven by the severity and duration of the COVID-19 pandemic, the pandemic’s impact on the United States and global economies and the timing, scope and effectiveness of federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company’s knowledge and control, and as a result, at this time the Company is unable to predict the cumulative impact, both in terms of severity and duration, that the COVID-19 pandemic will have on its business, operating results, cash flows and financial condition. However, the impact of the COVID-19 pandemic could be material if the current circumstances continue to exist for a prolonged period of time or worsen. Additionally, recent geopolitical events, such as the recent military conflict between Russia and Ukraine, may increase the severity of supply chain disruptions and further hinder our ability to source inventory for our vehicles. The conflict continues to evolve and its ultimate impact on the Company is uncertain, but a prolonged conflict may have a material negative impact on the Company’s business, operating results, cash flows, liquidity and financial condition. Although the Company has used the best current information available to it in its estimates, actual results could materially differ from the estimates and assumptions developed by management. Supply Chain Disruptions Negative global economic conditions, which the COVID-19 pandemic has contributed to, has impacted the Company’s ability to source certain critical inventory items. The series of restrictions imposed and the speed and nature of the recovery in response to the pandemic have placed burdens on the Company’s supply chain management, such as the semiconductor chip and battery cell shortage and supply limitations on vehicle bodies and aluminum. Despite supply chain disruptions, the Company has continued to source inventory for its vehicles and its purchasing team has been working with vendors to find alternative solutions to areas where there are supply chain constraints, and where appropriate and critical, has placed orders in advance of projected need to ensure inventory is able to be delivered in time for production plans. Inflation and Other Risks

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies The following is a summary of the significant accounting policies consistently applied in the preparation of the accompanying unaudited condensed consolidated financial statements: Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. They do not include all of the information and footnotes required by U.S. GAAP for complete audited financial statements. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Legacy Xos and Xos Services. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (primarily consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the years ended December 31, 2021 and 2020 presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 30, 2022. Restatement of Unaudited Condensed Consolidated Financial Statements Subsequent to the original issuance of the interim financial statements for the quarterly period ended June 30, 2022 on August 11, 2022, management determined, upon further analysis, that the Company’s previously issued unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2022 should be restated due to (1) errors in recording results of a physical inventory count, which caused inventories to be overstated and cost of goods sold to be understated for the six months ended June 30, 2022, and (2) errors in the improper recording of duplicate inventory receipts as well as improper and inaccurate recording of prepaid inventories, which caused inventories, prepaid inventories (included within Prepaid expenses and other current assets), accounts payable and accrued expenses (included within Other current liabilities) to be overstated for the three and six months ended June 30, 2022. The following tables reflect the impact of the restatement adjustments to the specific line items presented in our previously issued unaudited financial statements for the periods indicated (in thousands, except per share amounts): June 30, 2022 Condensed Consolidated Balance Sheets As Previously Reported Adjustments As Restated Inventories $ 62,197 $ (3,955) $ 58,242 Prepaid expenses and other current assets 20,971 (3,173) 17,798 Total current assets 168,035 (7,128) 160,907 Total assets 206,817 (7,128) 199,689 Accounts payable 8,761 (342) 8,419 Other current liabilities 21,767 (3,763) 18,004 Total current liabilities 30,528 (4,105) 26,423 Total liabilities 57,387 (4,105) 53,282 Accumulated deficit (34,746) (3,023) (37,769) Total stockholders' equity 149,430 (3,023) 146,407 Total liabilities and stockholders' equity $ 206,817 $ (7,128) $ 199,689 Three Months Ended June 30, 2022 Condensed Consolidated Statement of Operations and Comprehensive Loss As Previously Reported Adjustments Restated Cost of goods sold $ 14,891 $ 179 $ 15,070 Gross loss (5,125) (179) (5,304) Loss from operations (27,813) (179) (27,992) Loss before provision from income taxes (9,466) (179) (9,645) Net loss (9,467) (179) (9,646) Total comprehensive loss $ (9,617) $ (179) $ (9,796) Net loss per share Basic $ (0.06) $ — $ (0.06) Diluted $ (0.06) $ — $ (0.06) Six Months Ended June 30, 2022 Condensed Consolidated Statement of Operations and Comprehensive Loss As Previously Reported Adjustments Restated Cost of goods sold $ 25,077 $ 3,023 $ 28,100 Gross loss (8,280) (3,023) (11,303) Loss from operations (51,267) (3,023) (54,290) Loss before provision from income taxes (30,650) (3,023) (33,673) Net loss (30,653) (3,023) (33,676) Total comprehensive loss $ (31,629) $ (3,023) $ (34,652) Net loss per share Basic $ (0.19) $ (0.02) $ (0.21) Diluted $ (0.19) $ (0.02) $ (0.21) Six Months Ended June 30, 2022 Condensed Consolidated Statement of Legacy Xos Preferred Stock and Stockholders' Equity (Deficit) As Previously Reported Adjustments As Restated Net and comprehensive loss $ (31,629) $ (3,023) $ (34,652) Accumulated Deficit $ (34,746) $ (3,023) $ (37,769) Total Stockholders' Equity (Deficit) $ 149,430 $ (3,023) $ 146,407 Six Months Ended June 30, 2022 Condensed Consolidated Statement of Cash Flows As Previously Reported Adjustments Restated Net loss $ (30,653) $ (3,023) $ (33,676) Inventory reserves $ 2,212 $ (221) $ 1,991 Changes in operating assets and liabilities: Inventories $ (33,058) $ 4,176 $ (28,882) Prepaid expenses and other current assets $ (3,121) $ 3,173 $ 52 Accounts payable $ (2,102) $ (343) $ (2,445) Other liabilities $ 17,126 $ (3,762) $ 13,364 The remainder of the notes to the Company’s condensed consolidated financial statements have been updated and restated, as applicable, to reflect the impacts of the restatement described above. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, inventory valuation, incremental borrowing rates for assessing operating and financing lease liabilities, useful lives of property and equipment, earn-out shares liability, stock-based compensation, common stock warrant liability and product warranty liability. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial statements. Reclassifications Certain prior p eriod balances have been reclassified to conform to the current period presentation in the unaudited condensed consolidated financial statements and the accompanying notes , including (i) classification of operating expenses in the unaudited condensed consolidated statements of operations and comprehensive loss and (ii) presenting equipment leases as part of other current and non-current liabilities. The Company reclassified a portion of its payroll related expenses in general and administrative to sales and marketing and research and development. Additionally, the Company reclassified depreciation expense to general and administrative expense. These reclassifications have no effect on previously reported net loss. Inventory and Inventory Valuation The Company’s inventory, which includes raw materials, work in-process, and finished goods, is carried at the lower of cost or net realizable value (“NRV”). Inventory is valued using average costing, as that method accurately reflects the frequency of the Company’s inventory purchases. In the case of manufactured inventories and work in progress, cost includes an appropriate share of production overheads based on operating capacity. At the end of each reporting period, the Company evaluates whether its inventories are damaged, obsolete, or have material changes in price or other causes, and if so, a loss is recognized in the period in which it occurs. Inventory write-downs are also based on reviews for obsolescence determined primarily by future demand forecasts. If the Company’s inventory on-hand is in excess of future demand forecast, the excess amounts are written-off. The Company reserves for any excess or obsolete inventories when it is believed that the net realizable value of inventories is less than the carrying value. The Company also reviews its inventory to determine whether its carrying value exceeds the net amount realizable upon the ultimate sale of the inventory. NRV is the estimated selling price of inventory in the ordinary course of business, less estimated costs of completion, disposal, and transportation. At the end of each reporting period, the Company determines the estimated selling price of its inventory based on market conditions. Once inventory is written-down, a new, lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Warranty Liability Since 2021, the Company provides customers with a product warranty that assures that the products meet standard specifications and are free for periods typically between 2 to 5 years. The Company accrues warranty reserve for the products sold, which includes its best estimate of the projected costs to repair or replace items under warranties and recalls if identified. These estimates are based on actual claims incurred to date and an estimate of the nature, frequency and costs of future claims. These estimates are inherently uncertain given the Company’s relatively short history of sales, and changes to its historical or projected warranty experience may cause material changes to the warranty reserve in the future. Claims incurred under the Company’s standard product warranty programs are recorded based on open claims. Claims incurred in each of the three and six months ended June 30, 2022 were $6,000, respectively; no claims were incurred for the year ended December 31, 2021. The Company recorded warranty liability within other current liabilities in the consolidated balance sheets as of June 30, 2022 and December 31, 2021. The Company did not record warranty liability for the three or six months ended June 30, 2021 as the product warranty had not been established. The reconciliation of the change in the Company’s product liability balances during the three months and six months ended June 30, 2022 consisted of the following (in thousands) : Three Months Ended June 30, 2022 Six Months Ended June 30, 2022 Warranty liability, beginning of period $ 475 $ 177 Reduction in liability (payments) (6) (6) Increase in liability (new warranties) 363 661 Warranty liability, end of period $ 832 $ 832 Leases Upon inception of a contract, the Company evaluates if the contract, or part of the contract, contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term, and lease liabilities represent the Company's obligation to make lease payments arising from the lease. The lease liability is measured as the present value of the unpaid lease payments, and the ROU asset value is derived from the calculation of the lease liability, including prepaid lease payments, if any. Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, fees paid by the lessee to the owners of a special-purpose entity for restructuring the transaction, and probable amounts the lessee will owe under a residual value guarantee. Lease payments do not include (i) variable lease payments other than those that depend on an index or rate, (ii) any guarantee by the lessee of the lessor’s debt, or (iii) any amount allocated to non-lease components, if such election is made upon adoption, per the provisions of ASU 2016-02, Leases. When the Company cannot determine the actual implicit rate in a lease, it uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments. The Company gives consideration to its recent debt issuances, if any, as well as publicly available data for instruments with similar characteristics when calculating its incremental borrowing rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company's lease term includes any option to extend the lease when it is reasonably certain to be exercised based on considering all relevant economic factors. Operating expense charges from the lessor are accounted for on an accrual basis. The Company has elected not to separate the lease and non-lease components. The leases have remaining initial terms ranging from less than 1 year to 5 years . The Company reviews the carrying value of its right-of-use assets for impairment whenever events or changes in circumstances indicate that the recorded value may not be recoverable. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If the Company determines that an impairment exists, any related impairment loss is estimated based on fair values. Recent Accounting Pronouncements Issued and Adopted: ASC 842, Leases : In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), as subsequently amended, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors), and replaces the existing guidance in ASC 840, Leases . The new standard also requires lessees to recognize operating and finance lease liabilities and corresponding ROU assets on the balance sheet and to provide enhanced disclosures surrounding the amount, timing and uncertainty of cash flows arising from leasing arrangements. On January 1, 2022, the Company adopted ASC 842 using the modified retrospective method. The Company has presented financial results and applied its accounting policies for the period beginning January 1, 2022 under ASC 842, while prior period results and accounting policies have not been adjusted and are reflected under legacy GAAP pursuant to ASC 840. In connection with the adoption of ASC 842, the Company performed an analysis of contracts under ASC 840 to ensure proper assessment of leases (or embedded leases) in existence as of January 1, 2022. The Company elected the package of practical expedients permitted under ASC 842, which allows the Company not to reassess 1) whether any expired or existing contracts as of the adoption date are or contain a lease, 2) lease classification for any expired or existing leases as of the adoption date and 3) initial direct costs for any existing leases as of the adoption date. The most significant impact of applying ASC 842 was the recognition of ROU asset and lease liabilities for operating leases in its condensed consolidated balance sheets. On January 1, 2022, the Company recognized an initial operating ROU asset of $7.7 million and associated operating lease liab ilities of $7.7 million . Refer to Note 6 — Leases for further information regarding the impact of the adoption of ASU 2016-02 on the Company's financial statements, as well as its various accounting policies for each lease type. Recent Accounting Pronouncements Issued and not yet Adopted: ASU 2016-13, Financial Instruments — Credit Losses (“ASU 2016-13”): In June 2016, the FASB issued ASU 2016-13, which states the Company will be required to use an expected-loss model for its marketable debt securities, available-for sale, which requires that credit losses be presented as an allowance rather than as an impairment write-down. Reversals of credit losses (in situations in which the estimate of credit losses declines) is permitted in the reporting period that the change occurs. Current U.S. GAAP prohibits reflecting reversals of credit losses in current period earnings. At June 30, 2022 , the Company had $77.9 million in marketable debt securities, available for sale which would be subject to this new standard. As of December 31, 2021, these marketable debt securities, available for sale have an average credit rating of A and no impairment write-downs have been recorded. The Company is currently evaluating the impact of this new standard on its investment policy and investments and does not expect the standard to have a material impact on its financial statements at adoption or in subsequent periods. The Company expects to adopt the new standard effective January 1, 2023 .

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregated revenues by major source during the three and six months ended June 30, 2022 and 2021 consisted of the following ( in thousands ): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Product and service revenue Stepvans & vehicle incentives $ 8,561 $ — $ 15,424 $ 715 Powertrains 656 596 670 674 Fleet-as-a-Service 38 — 133 — Total product revenue 9,255 596 16,227 1,389 Ancillary revenue 511 — 570 — Total revenues $ 9,766 $ 596 $ 16,797 $ 1,389

Inventories

Inventories	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventory amounted to $58.2 million and $30.9 million, respectively, as of June 30, 2022 and December 31, 2021 and consisted of the following (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Raw materials $ 35,381 $ 20,382 Work in process 25,911 10,659 Finished goods — 901 Inventories, gross of reserves 61,292 31,942 Less: inventory reserve (3,050) (1,059) Inventories $ 58,242 $ 30,883

Selected Balance Sheet Data

Selected Balance Sheet Data	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Selected Balance Sheet Data	Selected Balance Sheet Data Prepaid expenses and other current assets as of June 30, 2022 and December 31, 2021 consisted of the following ( in thousands ): June 30, 2022 (As restated) (1) December 31, 2021 Prepaid inventories $ 12,562 $ 7,303 Prepaid insurance 1,102 4,996 Deposits (primarily relating to deposits on equipment purchases) 805 2,783 Assets held for sale 1,848 1,848 Prepaid licenses and subscriptions 741 801 Others 740 119 Total $ 17,798 $ 17,850 ____________ (1) For discussion on the restatement adjustments, see Note 2 – Basis of Presentation and Summary of Significant Accounting Policies – Restatement of Unaudited Condensed Consolidated Financial Statements. Other current liabilities as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Accrued expenses and other (2) $ 12,583 $ 4,303 Lease liabilities, current 3,520 482 Customer deposits 1,068 899 Warranty liability 833 177 Total $ 18,004 $ 5,861 ____________ (1) For discussion on the restatement adjustments, see Note 2 – Basis of Presentation and Summary of Significant Accounting Policies – Restatement of Unaudited Condensed Consolidated Financial Statements. (2) Primarily relates to accrued inventory purchases, personnel costs — wages, health benefits, vacation and other accruals.

Leases

Leases	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Leases	Leases A summary of the balances relating to the Company’s lease assets and liabilities as of June 30, 2022 consisted of the following (in thousands) : Balance Sheet Location June 30, 2022 Assets Operating leases Operating lease right-of-use assets, net $ 7,306 Equipment finance leases Property and equipment, net 7,734 Total Lease Assets $ 15,040 Liabilities Current Operating leases Other current liabilities $ 1,484 Equipment finance leases Other current liabilities 2,036 Sub-total $ 3,520 Non-current Operating leases Other non-current liabilities $ 5,950 Equipment finance leases Other non-current liabilities 4,788 Sub-total $ 10,738 Total Lease Liabilities $ 14,258 Operating Leases The Company has a 5-year office lease on its headquarter facility in Los Angeles, which commenced in January 2022, as well as certain other leases (both short-term and long-term) within the United States. The Company records lease expense on a straight-line basis over the lease term in general and administrative expense and cost of goods sold, depending on the nature and use of the leased asset. Total lease expense for the three months ended June 30, 2022 and 2021 was $0.4 million and $0.1 million, respectively. Total lease expense recorded was $0.9 million and $0.3 million, for the six months ended June 30, 2022 and 2021,respectively. Lease terms include renewal or termination options that the Company is reasonably certain to exercise. For leases with a term of 12 months or less, the Company has made an accounting policy election to not record a ROU asset and associated lease liability on its unaudited condensed consolidated balance sheet. Total lease expense recorded for these short-term leases was $0.3 million and $0.4 million for the three and six months ended June 30, 2022, respectively. Equipment Finance Leases The Company leases certain equipment facilities under finance leases that expire on various dates through 2027. The finance lease cost during the three and six months ended June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, Income Statement Location 2022 2021 2022 2021 Amortization General and administrative expense $ 78 $ 19 $ 238 $ 48 Interest accretion on finance lease liabilities Other income (expense), net 65 4 92 10 Total $ 143 $ 23 $ 330 $ 58 Supplemental Cash Flow Information, Weighted-Average Remaining Lease Term and Discount Rate The weighted-average remaining lease term and discount rates, as well as supplemental cash flow information as of and for the six months ended June 30, 2022 consisted of the following ( in thousands for the supplemental cashflow information ): Supplemental cashflow information: Cash paid for amounts included in the measurement of operating lease liabilities $ 808 ROU assets obtained in exchange for operating lease obligations $ 437 Weighted average remaining lease term: Operating leases 4.4 years Equipment finance leases 3.1 years Weighted average discount rate: Operating lease - IBR 5.5 % Equipment finance leases - rate implicit in the lease 7.8 % Maturity Analysis A summary of the undiscounted cash flows and a reconciliation to the Company’s lease liabilities as of June 30, 2022 consisted of the following (in thousands) : June 30, 2022 Operating Leases Equipment Finance Leases Total 2022 (remaining six months) $ 926 $ 1,311 $ 2,237 2023 1,860 2,408 4,268 2024 1,907 2,329 4,236 2025 1,963 1,224 3,187 2026 1,631 360 1,991 Thereafter 114 29 143 Total future minimum lease payments $ 8,401 $ 7,661 $ 16,062 Less: imputed interest 967 837 1,804 Present value of Lease Liabilities $ 7,434 $ 6,824 $ 14,258 Schedule of future minimum lease payments for operating and finance leases as of December 31, 2021 consisted of the following (in thousands) : December 31, 2021 Operating Leases Equipment Finance Leases Total 2022 $ 1,167 $ 482 $ 1,649 2023 1,158 442 1,600 2024 1,192 386 1,578 2025 1,228 401 1,629 2026 1,265 339 1,604 Thereafter 106 27 133 Total future minimum lease payments $ 6,116 $ 2,077 $ 8,193
Leases	Leases A summary of the balances relating to the Company’s lease assets and liabilities as of June 30, 2022 consisted of the following (in thousands) : Balance Sheet Location June 30, 2022 Assets Operating leases Operating lease right-of-use assets, net $ 7,306 Equipment finance leases Property and equipment, net 7,734 Total Lease Assets $ 15,040 Liabilities Current Operating leases Other current liabilities $ 1,484 Equipment finance leases Other current liabilities 2,036 Sub-total $ 3,520 Non-current Operating leases Other non-current liabilities $ 5,950 Equipment finance leases Other non-current liabilities 4,788 Sub-total $ 10,738 Total Lease Liabilities $ 14,258 Operating Leases The Company has a 5-year office lease on its headquarter facility in Los Angeles, which commenced in January 2022, as well as certain other leases (both short-term and long-term) within the United States. The Company records lease expense on a straight-line basis over the lease term in general and administrative expense and cost of goods sold, depending on the nature and use of the leased asset. Total lease expense for the three months ended June 30, 2022 and 2021 was $0.4 million and $0.1 million, respectively. Total lease expense recorded was $0.9 million and $0.3 million, for the six months ended June 30, 2022 and 2021,respectively. Lease terms include renewal or termination options that the Company is reasonably certain to exercise. For leases with a term of 12 months or less, the Company has made an accounting policy election to not record a ROU asset and associated lease liability on its unaudited condensed consolidated balance sheet. Total lease expense recorded for these short-term leases was $0.3 million and $0.4 million for the three and six months ended June 30, 2022, respectively. Equipment Finance Leases The Company leases certain equipment facilities under finance leases that expire on various dates through 2027. The finance lease cost during the three and six months ended June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, Income Statement Location 2022 2021 2022 2021 Amortization General and administrative expense $ 78 $ 19 $ 238 $ 48 Interest accretion on finance lease liabilities Other income (expense), net 65 4 92 10 Total $ 143 $ 23 $ 330 $ 58 Supplemental Cash Flow Information, Weighted-Average Remaining Lease Term and Discount Rate The weighted-average remaining lease term and discount rates, as well as supplemental cash flow information as of and for the six months ended June 30, 2022 consisted of the following ( in thousands for the supplemental cashflow information ): Supplemental cashflow information: Cash paid for amounts included in the measurement of operating lease liabilities $ 808 ROU assets obtained in exchange for operating lease obligations $ 437 Weighted average remaining lease term: Operating leases 4.4 years Equipment finance leases 3.1 years Weighted average discount rate: Operating lease - IBR 5.5 % Equipment finance leases - rate implicit in the lease 7.8 % Maturity Analysis A summary of the undiscounted cash flows and a reconciliation to the Company’s lease liabilities as of June 30, 2022 consisted of the following (in thousands) : June 30, 2022 Operating Leases Equipment Finance Leases Total 2022 (remaining six months) $ 926 $ 1,311 $ 2,237 2023 1,860 2,408 4,268 2024 1,907 2,329 4,236 2025 1,963 1,224 3,187 2026 1,631 360 1,991 Thereafter 114 29 143 Total future minimum lease payments $ 8,401 $ 7,661 $ 16,062 Less: imputed interest 967 837 1,804 Present value of Lease Liabilities $ 7,434 $ 6,824 $ 14,258 Schedule of future minimum lease payments for operating and finance leases as of December 31, 2021 consisted of the following (in thousands) : December 31, 2021 Operating Leases Equipment Finance Leases Total 2022 $ 1,167 $ 482 $ 1,649 2023 1,158 442 1,600 2024 1,192 386 1,578 2025 1,228 401 1,629 2026 1,265 339 1,604 Thereafter 106 27 133 Total future minimum lease payments $ 6,116 $ 2,077 $ 8,193

Recapitalization and Contingent

Recapitalization and Contingent Earn-out Shares Liability	6 Months Ended
	Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Recapitalization and Contingent Earn-out Shares Liability	Recapitalization and Earn-out Shares Liability Recapitalization As discussed in Note 1, on August 20, 2021, Legacy Xos and NextGen consummated the Business Combination contemplated by the Merger Agreement. Xos has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances: • Xos stockholders have the largest voting interest in the post-combination company; • The board of directors of Xos is authorized to be up to nine members and had six members designated at the time of closing, and Xos having the ability to nominate the majority of the members of the board of directors as of closing; • Xos management holds executive management roles (including Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and Chief Technology Officer, among others) for the post-combination company and is responsible for the day-to-day operations; • The post-combination company assumed the Xos name: “Xos, Inc.”; and • The intended strategy of the post-combination entity continued Legacy Xos’ strategy of being a leader in the electric vehicle industry. Accordingly, all historical financial information presented in these combined and consolidated financial statements represents the accounts of Legacy Xos and its wholly owned subsidiaries “as if” Legacy Xos is the predecessor and legal successor. The historical operations of Legacy Xos are deemed to be those of the Company. Thus, the financial statements included in this report reflect (i) the historical operating results of Legacy Xos prior to the business combination; (ii) the combined results of NextGen and Legacy Xos following the Business Combination; and (iii) the assets and liabilities of Legacy Xos at their historical cost. No step-up basis of intangible assets or goodwill was recorded in the business combination transaction consistent with the treatment of the transaction as a reverse capitalization. In connection with the Business Combination, each share of Legacy Xos Common Stock and Legacy Xos Preferred Stock issued and outstanding immediately prior to the Business Combination (with each share of Legacy Xos Preferred Stock being treated as if it were converted into Legacy Xos Common Stock immediately prior to the Business Combination) converted into the right to receive 1.956440 shares (the “Exchange Ratio”) of Common Stock. Also, in connection with the Business Combination, the following occurred: • the merger of Legacy Xos into a wholly owned subsidiary of NextGen, with Legacy Xos surviving the merger as a wholly owned subsidiary of NextGen, with the combined company is referred to as “Xos”; • 142,584,621 shares of Common Stock issued, including: (i) the Legacy Xos’ Common Stock, and (ii) Legacy Xos’ Preferred Stock, including the exercise and conversion of Legacy Xos’ Preferred Stock warrant (as if the Legacy Xos Preferred Stock had converted into the Legacy Xos’ Common Stock immediately prior to the reverse merger); • the issuance and sale of 19,600,000 shares of Common Stock (PIPE investment) for a purchase price of $10.00 per share and an aggregate purchase price of $196.0 million (which excludes the sale of 2,000,000 shares in the aggregate for a purchase price of $10.00 per share and an aggregate purchase price of $20.0 million pursuant to an offering of Common Stock by the Founders of Legacy Xos). On the Closing Date, one of the PIPE Investors, Grantchester C Change, LLC., did not fund their $4.0 million committed amount under the binding Subscription Agreement.; • the settlement of the outstanding underwriting fees incurred in connection with the initial public offering of NextGen on October 9, 2020, for which the final cash amount owed was $11.2 million; • the settlement of the direct and incremental transaction costs incurred prior to, or concurrent with, the closing of the business combination in the amount of $44.2 million, which are recorded as reduction to additional paid-in capital; • the recognition of contingent earn-out interests provision as liability with a fair value of $101.7 million on the day of the merger consummation; and, • the assumption of the Public Warrants (12,499,964 units) and Private Placement Warrants (6,333,334 units) at fair value of $17.9 million on the day of merger consummation. Contingent Earn-out Shares Liability The Company has a contingent obligation to issue 16.2 million shares (the “Earn-out Shares”) of Common Stock and grant 261,000 restricted stock units (“Earn-out RSUs”) to certain stockholders and employees upon the achievement of certain market share price milestones within specified periods following the Business Combination on August 20, 2021. The Earn-out Shares will be issued in tranches based on the following conditions: i. If the volume-weighted average closing share price (“VWAP”) of the Common Stock equals or exceeds $14.00 per share for any 10 trading days within any consecutive 20-trading day period between the merger closing date and the five year anniversary of such closing date (“Earn-out Period”), then the Company is required to issue an aggregate of 5.4 million shares (“Tranche 1 Earn-out Shares”) of Common Stock to holders with the contingent right to receive Earn-out Shares (excluding any Earn-out RSUs). If after Closing and during the Earn-out Period, there is a Change in Control (as defined in the Merger Agreement), the Company is required to issue Tranche 1 Earn-out Shares when the value per share of the Company is equal to or greater than $14.00 per share, but less than $20.00. If there is a change in control where the value per share of commons stock is less than $14.00, then the Earn-out Shares shall terminate prior to the end of the Earn-out Period and no common stock shall be issuable. ii. If the VWAP of the Common Stock equals or exceeds $20.00 per share for any 10 trading days within any consecutive 20-trading day period during the Earn-out Period, then the Company is required to issue an aggregate of 5.4 million shares (“Tranche 2 Earn-out Shares”) of Common Stock to holders with the contingent right to receive Earn-out Shares (excluding any Earn-out RSUs). If after Closing and during the Earn-out Period, there is a Change in Control (as defined in the Merger Agreement), the Company is required to issue Tranche 2 Earn-out Shares when the value per share of the Company is equal to or greater than $20.00 per share, but less than $25.00. iii. If the VWAP of the Common Stock equals or exceeds $25.00 per share for any 10 trading days within any consecutive 20-trading day period during the Earn-out Period, then the Company is required to issue an aggregate of 5.4 million shares (“Tranche 3 Earn-out Shares”) of Common Stock to holders with the contingent right to receive Earn-out Shares (excluding any Earn-out RSUs). If after Closing and during the Earn-out Period, there is a Change in Control (as defined in the Merger Agreement), the Company is required to issue Tranche 3 Earn-out Shares when the valuer per share of the Company is equal to or greater than $25.00 per share. Pursuant to the guidance under ASC 815, Derivatives and Hedging, the right to Earn-out Shares was classified as a Level 3 fair value measurement liability, and the increase or decrease in the fair value during the reporting period is recognized in the condensed consolidated statement of operations accordingly. The fair value of the Earn-out Shares liability was estimated using the Monte Carlo simulation of the stock prices based on historical and implied market volatility of a peer group of public companies. The Company recognized a gain on the fair value change in Earn-out Shares liability of $14.9 million and $17.5 million in its unaudited condensed consolidated statements of operations during the three and six months ended June 30, 2022, respectively.

Investments

Investments	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Amortized cost, gross unrealized gains/losses in accumulated other comprehensive loss and fair value of marketable debt securities, available-for-sale, by type of security as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Short-term investments: Corporate debt security $ 42,945 $ — $ (695) $ 42,250 U.S. treasuries 5,608 — (74) 5,534 Asset-backed security and other 5,868 — (77) 5,791 Non-U.S. government and supranational bonds 9,179 — (107) 9,072 Certificate of deposit 2,004 — — 2,004 $ 65,604 $ — $ (953) $ 64,651 Long-term investments: Corporate debt security $ 11,580 $ — $ (349) $ 11,231 Asset-backed security and other 2,042 — (55) 1,987 $ 13,622 $ — $ (404) $ 13,218 December 31, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Short-term investments: Corporate debt security $ 71,406 $ — $ (57) $ 71,349 U.S. treasuries 3,415 — (7) 3,408 Asset-backed security and other 2,555 — (4) 2,551 Non-U.S. government and supranational bonds 16,405 1 (19) 16,387 Certificate of deposit 1,001 — — 1,001 $ 94,782 $ 1 $ (87) $ 94,696 Long-term investments: Corporate debt security $ 42,703 $ — $ (246) $ 42,457 U.S. treasuries 2,201 — (5) 2,196 Asset-backed security and other 5,438 — (28) 5,410 Non-U.S. government and supranational bonds 3,769 — (16) 3,753 Certificate of deposit 1,000 — — 1,000 $ 55,111 $ — $ (295) $ 54,816 The Company’s investments in marketable debt securities, available-for-sale that have been in a continuous unrealized loss position by type of security as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Less than 12 months 12 months or greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Corporate debt security $ 53,481 $ (1,044) $ — $ — $ 53,481 $ (1,044) US treasuries 5,534 (74) — — 5,534 (74) Asset-backed security and other 7,778 (132) — — 7,778 (132) Non-U.S. government and supranational bonds 9,072 (107) — — 9,072 (107) Certificates of deposit 2,004 — — — 2,004 — $ 77,869 $ (1,357) $ — $ — $ 77,869 $ (1,357) December 31, 2021 Less than 12 months 12 months or greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Corporate debt security $ 113,806 $ (303) $ — $ — $ 113,806 $ (303) US treasuries 5,604 (12) — — 5,604 (12) Asset-backed security and other 7,961 (32) — — 7,961 (32) Non-U.S. government and supranational bonds 20,140 (34) — — 20,140 (34) Certificates of deposit 2,001 — — — 2,001 — $ 149,512 $ (381) $ — $ — $ 149,512 $ (381) Gross realized gains and gross realized losses from the sales of the Company’s marketable debt securities, available-for-sale for the three and six months ended June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Gross realized gains $ — $ — $ — $ — Gross realized losses $ (63) $ — $ (69) $ — Amortized cost and fair value of marketable debt securities, available-for-sale by contractual maturity as of June 30, 2022 consisted of the following ( in thousands , except weighted average data ): Amortized Cost Fair Value Due in one year or less $ 65,604 $ 64,651 Due after one year through five years 13,622 13,218 $ 79,226 $ 77,869 Weighted average contractual maturity 0.7 years Amortized cost and fair value of marketable debt securities, available-for-sale by contractual maturity as of December 31, 2021 consisted of the following ( in thousands , except weighted average data ): Amortized Cost Fair Value Due in one year or less $ 94,782 $ 94,696 Due after one year through five years 55,111 54,816 $ 149,893 $ 149,512 Weighted average contractual maturity 0.8 years Actual maturities may differ from contractual maturities because certain issuers may have the right or obligation to prepay certain obligations with or without penalties.

Equity

Equity	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note And Temporary Equity [Abstract]
Equity	Equity Xos Common and Preferred Stock The Company is authorized to issue two classes of stock to be designated, respectively, “Common Stock” and “Preferred Stock.” The total number of shares which the Company is authorized to issue is 1,010,000,000 shares. 1,000,000,000 shares shall be Common Stock, each having a par value of one-hundredth of one cent ($0.0001). 10,000,000 shares shall be Preferred Stock, each having a par value of one-hundredth of one cent ($0.0001). Voting Rights : Each outstanding share of Common Stock shall entitle the holder thereof to one vote on each matter properly submitted to the stockholders of the Company for their vote; provided, however, that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon by law or pursuant to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock). Preferred Stock : The Preferred Stock may be issued from time to time in one or more series. The Board of Directors of the Company (the “Board of Directors”) is hereby expressly authorized to provide for the issue of all or any number of the shares of the Preferred Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such shares and as may be permitted by the Delaware General Corporation Law (the “DGCL”). The Board of Directors is also expressly authorized to increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares of such series then outstanding) the number of shares of any series subsequent to the issuance of shares of that series. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. Legacy Xos’ Preferred Stock During the fourth quarter of 2020, Legacy Xos executed a financing round and issued shares of preferred stock (the “Series A Financing’’). The Series A Financing included the authorization of 25,794,475 shares of Legacy Xos Preferred Stock in classes A through A-10. The shares of Class A Legacy Xos Preferred Stock were allocated to investors who contributed new money to Legacy Xos, while the shares of Class A-1 through A-10 Legacy Xos Preferred Stock were issued in exchange to convertible note holders. As part of this raise, 1,411,764 shares of Class A Legacy Xos Preferred Stock and one warrant exercisable for 319,411 shares of Class A Legacy Xos Preferred Stock were issued for aggregate cash proceeds of $9.6 million and a subscription receivable for $2.4 million. During the quarter ended March 31, 2021, the Legacy Xos issued an additional 3,739,846 shares of Class A Legacy Xos Preferred Stock raising $31.8 million in cash proceeds, and the conversion of the SAFE agreement (Simple Agreement for Future Equity) issued to Elemental Excelerator (the “SAFE Note”). As part of this transaction, Legacy Xos converted $21.5 million of convertible notes and $2.5 million in accrued interest into 21,570,308 shares of Class A-1 through A-10 Legacy Xos Preferred Stock. These exchanges from convertible notes into shares of Legacy Xos Preferred Stock included transactions with both related and unrelated parties (refer to Note 14). The differences between the total carrying value of the converted notes held by third parties, and the fair value of the issued shares of Legacy Xos Preferred stock, was recorded as realized loss on debt extinguishment in the consolidated statement of operations. We have determined the fair value of the issued shares of Legacy Xos Preferred Stock in connection with the note conversion using market rates experienced in other non-related party transactions, through the issuance of shares of Legacy Xos Preferred Stock. As some of the converted third-party notes have voting rights and others do not, the fair value of non-voting shares were reduced by 3%. Concurrent with the Business Combination, outstanding shares of Legacy Xos Preferred Stock were converted into shares of Common Stock in accordance with the Exchange Ratio. Standby Equity Purchase Agreement On March 23, 2022, the Company entered into a Standby Equity Purchase Agreement (the "SEPA") with YA II PN, Ltd. (“Yorkville”), whereby the Company has the right, but not the obligation, to sell to Yorkville up to $125.0 million of shares of its Common Stock at its request any time during the 36 months following the execution of the SEPA, subject to certain conditions. The Company expects to use any net proceeds for working capital and general corporate purposes. As consideration for Yorkville’s commitment to purchase shares of common stock at the Company’s direction upon the terms and subject to the conditions set forth in the purchase agreement, upon execution of the purchase agreement, the Company issued 18,582 shares of common stock to Yorkville. During the three months ended June 30, 2022, the Company issued 1,809,515 shares of Common Stock under the SEPA for proceeds of $4.3 million. As of June 30, 2022, the remaining commitment available under the agreement was $120.7 million.

Derivative Instruments

Derivative Instruments	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Common Stock Warrant Liability Public and Private Placement Warrants As of June 30, 2022, the Company had 18,613,299 Public Warrants and 219,999 Private Placement Warrants outstanding, with fair values of $4.2 million and $49,000, respectively. The Public Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire on August 20, 2026 or earlier upon redemption or liquidation. The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the units and only whole Public Warrants will trade. The Public Warrants became exercisable; provided that the Company has an effective registration statement under the Securities Act covering the issuance of the Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Warrants on a cashless basis under the circumstances specified in the warrant agreement). A registration statement was filed with the SEC covering the issuance of the Common Stock issuable upon exercise of the Warrants, and the Company will use its commercially reasonable efforts to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of Common Stock until the Public Warrants expire or are redeemed. If the shares of Common Stock are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, requires holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Common Stock issuable upon exercise of the Private Placement Warrants were not transferable, assignable or salable until September 19, 2021, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of Warrants for cash when the price per Common Stock equals or exceeds $18.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except as described above with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon not less than 30 days’ prior written notice of redemption to each Warrant holder; and • if, and only if, the last reported sale price of Common Stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like). The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Common Stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those Common Stock is available throughout the 30-day redemption period. If and when the Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants for Common Stock when the price per share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (including both Public Warrants and Private Placement Warrants): • in whole and not in part; • at $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Common Stock; • if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and • if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Common Stock shall mean the average reported last sale price of Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Warrants. In no event will the Company be required to net cash settle any Warrant. The Warrants may also expire worthless.

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation 2018 Stock Plan On November 27, 2018, the Legacy Xos’ board of directors and stockholders adopted the 2018 Stock Plan. There are no shares available for issuance under the 2018 Stock Plan; however, the 2018 Stock Plan continues to govern the terms and conditions of the outstanding awards granted under the 2018 Stock Plan. Options As of June 30, 2022, there were 1,786,679 Options outstanding under the 2018 Stock Plan. The amount and terms of Option grants were determined by the board of directors of Legacy Xos. The Options granted under the 2018 Stock Plan generally expire within 10 years from the date of grant and generally vest over 4 years, at the rate of 25% on the first anniversary of the date of grant and ratably on a monthly basis over the remaining 36-month period thereafter based on continued service. Stock option activity during the six months ended June 30, 2022 consisted of the following: Options Weighted Average Fair Value Weighted Average Exercise Price Weighted Average Remaining Years Intrinsic Value December 31, 2021 — Options outstanding 1,838,759 $ 0.02 $ 0.02 8.22 $ 5,756,797 Granted — — — Exercised 400 0.02 0.02 Forfeited 3,678 0.03 0.02 March 31, 2022 — Options outstanding 1,834,681 $ 0.02 $ 0.02 7.98 $ 5,450,514 Granted — — — Exercised 38,693 0.02 0.04 Forfeited 9,309 0.02 0.03 June 30, 2022 — Options outstanding 1,786,679 $ 0.02 $ 0.02 7.69 $ 3,253,977 June 30, 2022 — Options vested and exercisable 767,020 $ 0.02 $ 0.02 7.48 $ 1,396,965 Aggregate intrinsic value represents the difference between the exercise price of the options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the three months ended June 30, 2022 and 2021 were approxi mately $114,000 a nd $0, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2022 and 2021 were approximately $115,000 and $6,000, respectively. The Company estimates the fair value of options utilizing the Black-Scholes option pricing model, which is dependent upon several variables, including expected option term, expected volatility of the Company's share price over the expected term, expected risk-free rate and expected dividend yield rate. There were no option grants during the three and six months ended June 30, 2022 and 2021. 2021 Equity Plan On August 19, 2021 the Company’s stockholders approved the 2021 Equity Plan, which was ratified by the Company’s board of directors on August 20, 2021. The 2021 Equity Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”) to employees, including employees of any parent or subsidiary, and for the grant of no statutory stock options (“NSOs”), stock appreciation rights, restricted stock awards, RSUs, performance awards and other forms of awards to employees, directors and consultants, including employees and consultants of Xos’ affiliates. As of June 30, 2022, there were 20,431,516 shares of Common Stock available for issuance under the 2021 Equity Plan. RSU activity during the six months ended June 30, 2022 consisted of the following: RSUs Weighted Average Grant Date Fair Value Weighted Average Fair Value December 31, 2021 — RSU outstanding 1,844,820 $ 3.60 $ 5,811,183 Granted 1,618,442 2.67 3,960,984 Vested 133,349 3.21 347,382 Forfeited 117,532 3.38 279,746 March 31, 2022 — RSU outstanding 3,212,381 $ 3.27 $ 9,605,019 Granted 724,299 2.51 1,818,247 Vested 88,730 3.48 228,923 Forfeited 208,375 3.14 530,965 June 30, 2022 — RSU outstanding 3,639,575 $ 3.12 $ 6,696,818 The Company’s recognized stock-based compensation expense (including earn-out RSUs) in the condensed consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2022, and 2021 consisted of the following ( in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of goods sold $ 198 $ — $ 227 $ — Research and development 93 — 354 — Sales and marketing 36 — 94 — General and administrative 751 1 1,794 3 Total $ 1,078 $ 1 $ 2,469 $ 3 The unamortized stock-based compensation expense was $9.3 million as of June 30, 2022, and weighted average remaining amortization period as of June 30, 2022 was 3.12 years . The aggregate fair value of RSUs that vested w a s $0.2 and $0.6 during the three and six months ended June 30, 2022, respectively .

Property and Equipment, net

Property and Equipment, net	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, net	Property and Equipment, net Property and equipment, net consisted of the following at June 30, 2022 and December 31, 2021 (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Equipment $ 8,985 $ 5,244 Furniture & fixtures 168 141 Company vehicles 629 153 Leasehold improvements 626 626 Computers, software and related equipment 1,762 1,289 Construction in progress 6,930 1,444 Property and Equipment, gross 19,100 8,897 Accumulated depreciation (2,346) (1,471) Property and Equipment, net $ 16,754 $ 7,426 ____________ (1) For discussion on the restatement adjustments, see Note 2 – Basis of Presentation and Summary of Significant Accounting Policies – Restatement of Unaudited Condensed Consolidated Financial Statements.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating and Finance Leases Refer to Note 6, Leases for future minimum lease commitments. Legal Contingencies Legal claims may arise from time to time in the normal course of business, the results of which may have a material effect on the Company’s accompanying consolidated financial statements. As of June 30, 2022 and December 31, 2021, the Company was not a party to any legal proceedings, that individually or in the aggregate, are reasonably expected to have a material adverse effect on the Company’s results of operations, financial condition or cash flows.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Company leases property in North Hollywood, California from Valley Industrial Properties which is owned by the Sunseeker Trust. The Sunseeker Trust is an irrevocable trust with the beneficiary being the mother of the CEO, Dakota Semler. Rent expense during each of the three months ended June 30, 2022 and 2021 totaled $35,000, respectively. Rent expense during each of the six months ended June 30, 2022 and 2021 totaled $70,000, respectively. The Company has contract manufacturing agreements with Metalsa S.A. de C.V. and Fitzgerald Manufacturing Partners. We utilize Metalsa, a Mexico-based automotive supplier, to provide parts and manufacturing services. Metalsa had an investment in the Company in the form of a convertible note payable which was converted as part of the Series A Financing (see Note 10 above). Si milarly, we utilize Fitzgerald Manufacturing Partners to provide parts and manufacturing services; the owner is a stockholder of the Company. We also have lease agreements with Fitzgerald Manufacturing Partners, for which we recorded rent expense of $189,000 and $361,000 during the three and six months ended June 30, 2022. No rent expense was recorded for these lease agreements during the three and six months ended June 30, 2021. The Company had a partial recourse promissory note in the amount of $364,000 due from the COO, Giordano Sordoni. The note was utilized to exercise options provided to him by the Company. Interest is compounded annually at a rate of 2.38%. The note was issued in the amount of $364,000 on June 24, 2019. The full balance and interest of $15,000 was forgiven by the Company during the first quarter of 2021. The Company converted 34 notes payable with outstanding carrying value of $18.9 million from related parties into 19,664,000 preferred shares of Legacy Xos Preferred Stock as described above in Note 9 - Equity . These related parties consisted of the CEO, COO, board members, board advisors, and various trusts whose beneficiaries are relatives of the CEO.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rate during the three months ended June 30, 2022 and 2021 was (0.01)% and 0%, respectively. The effective tax rate during the six months ended June 30, 2022 and 2021 was (0.01)% and 0%, respectively. State taxes coupled with losses not benefited resulted in an effective tax rate, below the statutory tax rate of 21% for the six months ended June 30, 2022. The Company recognizes tax benefits related to positions taken, or expected to be taken, on its tax returns, only if the positions are "more-likely-than-not" sustainable. Once this threshold has been met, the Company's measurement of its expected tax benefits is recognized in its financial statements. The Company does not have any uncertain tax positions that meet this threshold as of June 30, 2022 and December 31, 2021. The Company files income tax returns with the Internal Revenue Service and the taxing authorities of various states. The tax periods 2018 through 2021 remain open in most jurisdictions. The Company is not currently under examination by income tax authorities in any federal or state jurisdiction. At June 30, 2022, the Company's deferred income taxes were in a net asset position mainly due to deferred tax assets generated by net operating losses. The Company assesses the likelihood that its deferred tax assets will be realized. A full review of all positive and negative evidence needs to be considered, including the Company's current and past performance, the market environments in which the Company operates, the utilization of past tax credits, length of carryback and carryforward periods, as well as tax planning strategies that might be implemented. Management believes that, based on a number of factors, it is more likely than not, that all or some portion of the deferred tax assets may not be realized; and accordingly, for the periods ended June 30, 2022 and 2021, the Company has provided a valuation allowance against net US deferred tax assets.

Net Loss per Share

Net Loss per Share	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per Share Basic and diluted net loss per share during the three and six months ended June 30, 2022 and 2021 consisted of the following ( in thousands , except per share amounts ): Three Months Ended June 30, Six Months Ended June 30, 2022 (As restated) (1) 2021 2022 (As restated) (1) 2021 Numerator: Net income (loss) $ (9,646) $ (9,158) $ (33,676) $ (23,008) Denominator: Basic Weighted average common shares outstanding — basic 164,041 72,389 163,606 72,372 Basic net loss per share $ (0.06) $ (0.13) $ (0.21) $ (0.32) Diluted Weighted average common shares outstanding from above 164,041 72,389 163,606 72,372 Add: dilutive effect of options — — — — Add: dilutive effect of RSUs — — — — Weighted average common shares outstanding 164,041 72,389 163,606 72,372 Diluted net loss per share $ (0.06) $ (0.13) $ (0.21) $ (0.32) ____________ (1) For discussion on the restatement adjustments, see Note 2 – Basis of Presentation and Summary of Significant Accounting Policies – Restatement of Unaudited Condensed Consolidated Financial Statements. Potential weighted average shares that were excluded from the computation of diluted net income (loss) per share because their effect was anti-dilutive as of June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contingent earn-out shares 16,422 — 16,422 — Common stock public and private warrants 18,833 — 18,833 — Restricted stock units 708 — 717 — Stock options 1,783 2,339 1,798 2,390

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements ASC 820, Fair Value Measurements and Disclosures , clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based upon assumptions that market participants would use in pricing an asset or liability. U.S. GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. As presented in the tables below, this hierarchy consists of three broad levels: • Level 1: Quoted prices in active markets for identical assets and liabilities. • Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs or significant value drivers are observable. • Level 3: Significant inputs to the valuation model are unobservable and significant to the overall fair value measurement of the assets or liabilities. Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, investments in marketable debt securities, available-for-sale, accounts payable, other current liabilities, public and private placement warrants, and the contingent earn-out shares liability. The fair value of cash and accounts receivable approximates carrying value due to their short-term maturity. As required by ASC 820, assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to their fair value measurement. Derivative financial instruments which are required to be measured at fair value on a recurring basis are measured at fair value using Level 3 inputs for all periods presented. Level 3 inputs are unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Assets and liabilities carried at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 2,207 $ 2,207 $ — $ — $ 2,207 $ 2,207 $ — $ — Short-Term Investments: U.S. treasuries $ 5,534 $ 5,534 $ — $ — Corporate debt security 42,250 — 42,250 — Asset-backed security and other 5,791 — 5,791 — Non-U.S. government and supranational bonds 9,072 — 9,072 — Certificate of Deposit 2,004 — 2,004 — $ 64,651 $ 5,534 $ 59,117 $ — Long-Term Investments: Corporate debt security $ 11,231 $ — $ 11,231 $ — Asset-backed security and other 1,987 — 1,987 — $ 13,218 $ — $ 13,218 $ — Total Financial Assets $ 80,076 $ 7,741 $ 72,335 $ — Financial Liabilities: Private Placement Warrants $ 49 $ — $ 49 $ — Public Warrants 4,178 4,178 — — Contingent Earn-out Shares liability 11,894 — — 11,894 Total Financial Liabilities $ 16,121 $ 4,178 $ 49 $ 11,894 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets. December 31, 2021 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 5,868 $ 5,868 $ — $ — Non-U.S. government and supranational bonds 647 — 647 — Corporate debt security 1,805 — 1,805 — $ 8,320 $ 5,868 $ 2,452 $ — Short-Term Investments: U.S. treasuries $ 3,408 $ 3,408 $ — $ — Corporate debt security 71,349 — 71,349 — Asset-backed security and other 2,551 — 2,551 — Non-U.S. government and supranational bonds 16,387 — 16,387 — Certificate of Deposit 1,001 — 1,001 — $ 94,696 $ 3,408 $ 91,288 $ — Long-Term Investments: U.S. treasuries $ 2,196 $ 2,196 $ — $ — Corporate debt security 42,457 — 42,457 — Asset-backed security and other 5,410 — 5,410 — Non-U.S. government and supranational bonds 3,753 — 3,753 — Certificate of Deposit 1,000 — 1,000 — $ 54,816 $ 2,196 $ 52,620 $ — Total Financial Assets $ 157,832 $ 11,472 $ 146,360 $ — Financial Liabilities: Private Placement Warrants $ 140 $ — $ 140 $ — Public Warrants 7,356 7,356 — — Contingent Earn-out Shares liability 29,240 — — 29,240 Total Financial Liabilities $ 36,736 $ 7,356 $ 140 $ 29,240 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets. The changes in the fair value of Level 3 financial liabilities during the three six months ended June 30, 2022 consisted of the following (in thousands): Three months ended June 30, 2022 Six months ended June 30, 2022 Fair value, beginning of period $ 26,938 $ 29,240 Recognition of earn-out RSUs (174) 148 Change in fair value during the period (14,870) (17,494) Fair value, end of period $ 11,894 $ 11,894 Significant unobservable inputs related to Level 3 earn-out shares liability consisted of the following as of June 30, 2022: June 30, 2022 Stock price $1.84 Stock price volatility 80.0% Expected term 4.14 years Risk-free interest rate 3.0%

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company evaluated all events or transactions that occurred through August 11, 2022, t he date the condensed consolidated financial statements were issued. Convertible Debentures On Augus t 9, 2022, the Company entered into a securities purchase agreement with Yorkville for the issuance of convertible debentures in the principal amount of up to $35.0 million (the “Convertible Debentures”). $20.0 million in principal amount of Convertible Debentures was issued on August 11, 2022, and an additional $15.0 million in principal amount will be issued to Yorkville upon the effectiveness of the registration statement registering the resale of Common Stock resulting from the conversion of the Convertible Debentures. The maturity date of the Convertible Debentures shall be November 11, 2023, which may be extended by an additional three months in certain instances. The Convertible Debentures bear interest at an annual rate of 6.0%, payable at maturity, which will increase to an annual rate of (i) 10.0% upon the occurrence and during the continuance of an event of default, and (ii) 7.5% for so long as “Registration Event” (as defined in the Convertible Debenture) remains in effect in accordance with the registration rights agreement. The Convertible Debentures provide a conversion right, in which Yorkville may, at any time after the issuance date, convert any portion of the principal amount of the Convertible Debenture, together with any accrued but unpaid interest, into shares of Common Stock at the lower of (i) $2.4733 per share or (ii) 97% of the lowest daily volume weighted average price of the Common Stock during the three trading days immediately preceding the date of conversion (but not lower than a floor price of $0.50 per share, subject to adjustment in accordance with the terms of the Convertible Debentures). Convertible Notes On August 9, 2022, the Company entered into an agreement with Aljomaih Automotive Co. (“Aljomaih”) for the issuance of convertible note with a principal amount of $20.0 million and a maturity date of August 11, 2025 (the “Note”). The Note includes an option to issue and sell additional convertible notes in a principal amount of up to an additional $20.0 million, upon the mutual consent of both parties by November 30, 2022, on terms and conditions to be negotiated in good faith. The Note bears interest at a rate of 10.0% per annum, payable at maturity in validly issued, fully paid and non-assessable shares of Common Stock, calculated based on the 10-day volume weighted average price ending on the trading day immediately prior to the applicable payment date, unless earlier converted or paid. The conversion price for the Note will initially be equal to $2.3817 per share, subject to adjustment in some events pursuant to the terms of the Note.

Accounting Policies (Policies)

Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Business Combination	Xos, Inc. was initially incorporated on July 29, 2020 as a Cayman Islands exempted company under the name “NextGen Acquisition Corporation” (“NextGen”). On August 20, 2021, the transactions contemplated by the Agreement and Plan of Merger, as amended on May 14, 2021, by and among NextGen, Sky Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of NextGen (“Merger Sub”), and Xos, Inc., a Delaware corporation (now known as Xos Fleet, Inc., “Legacy Xos”), were consummated (the “Closing”), whereby Merger Sub merged with and into Legacy Xos, the separate corporate existence of Merger Sub ceased and Legacy Xos became the surviving corporation and a wholly owned subsidiary of NextGen (such transaction the “Merger” and, collectively with the Domestication, the “Business Combination”). As a result, Xos became the publicly traded entity listed on the Nasdaq Global Market.
Emerging Growth Company	Section 102(b)(1) of the Jumpstart its Business Startups Act (“JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement declared effective pursuant to the Securities Act of 1933, as amended (the “Securities Act”), or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard, until such time the Company is no longer considered to be an emerging growth company. At times, the Company may elect to early adopt a new or revised standard.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies - (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. They do not include all of the information and footnotes required by U.S. GAAP for complete audited financial statements. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Legacy Xos and Xos Services. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (primarily consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the years ended December 31, 2021 and 2020 presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 30, 2022.
Use of Estimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, inventory valuation, incremental borrowing rates for assessing operating and financing lease liabilities, useful lives of property and equipment, earn-out shares liability, stock-based compensation, common stock warrant liability and product warranty liability. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial statements.
Reclassifications	Certain prior p eriod balances have been reclassified to conform to the current period presentation in the unaudited condensed consolidated financial statements and the accompanying notes , including (i) classification of operating expenses in the unaudited condensed consolidated statements of operations and comprehensive loss and (ii) presenting equipment leases as part of other current and non-current liabilities. The Company reclassified a portion of its payroll related expenses in general and administrative to sales and marketing and research and development. Additionally, the Company reclassified depreciation expense to general and administrative expense. These reclassifications have no effect on previously reported net loss.
Inventory and Inventory Valuation	The Company’s inventory, which includes raw materials, work in-process, and finished goods, is carried at the lower of cost or net realizable value (“NRV”). Inventory is valued using average costing, as that method accurately reflects the frequency of the Company’s inventory purchases. In the case of manufactured inventories and work in progress, cost includes an appropriate share of production overheads based on operating capacity. At the end of each reporting period, the Company evaluates whether its inventories are damaged, obsolete, or have material changes in price or other causes, and if so, a loss is recognized in the period in which it occurs. Inventory write-downs are also based on reviews for obsolescence determined primarily by future demand forecasts. If the Company’s inventory on-hand is in excess of future demand forecast, the excess amounts are written-off. The Company reserves for any excess or obsolete inventories when it is believed that the net realizable value of inventories is less than the carrying value. The Company also reviews its inventory to determine whether its carrying value exceeds the net amount realizable upon the ultimate sale of the inventory. NRV is the estimated selling price of inventory in the ordinary course of business, less estimated costs of completion, disposal, and transportation. At the end of each reporting period, the Company determines the estimated selling price of its inventory based on market conditions. Once inventory is written-down, a new, lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Warranty Liability	Since 2021, the Company provides customers with a product warranty that assures that the products meet standard specifications and are free for periods typically between 2 to 5 years. The Company accrues warranty reserve for the products sold, which includes its best estimate of the projected costs to repair or replace items under warranties and recalls if identified. These estimates are based on actual claims incurred to date and an estimate of the nature, frequency and costs of future claims. These estimates are inherently uncertain given the Company’s relatively short history of sales, and changes to its historical or projected warranty experience may cause material changes to the warranty reserve in the future. Claims incurred under the Company’s standard product warranty programs are recorded based on open claims. Claims incurred in each of the three and six months ended June 30, 2022 were $6,000, respectively; no claims were incurred for the year ended December 31, 2021. The Company recorded warranty liability within other current liabilities in the consolidated balance sheets as of June 30, 2022 and December 31, 2021. The Company did not record warranty liability for the three or six months ended June 30, 2021 as the product warranty had not been established.
Leases	Upon inception of a contract, the Company evaluates if the contract, or part of the contract, contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term, and lease liabilities represent the Company's obligation to make lease payments arising from the lease. The lease liability is measured as the present value of the unpaid lease payments, and the ROU asset value is derived from the calculation of the lease liability, including prepaid lease payments, if any. Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, fees paid by the lessee to the owners of a special-purpose entity for restructuring the transaction, and probable amounts the lessee will owe under a residual value guarantee. Lease payments do not include (i) variable lease payments other than those that depend on an index or rate, (ii) any guarantee by the lessee of the lessor’s debt, or (iii) any amount allocated to non-lease components, if such election is made upon adoption, per the provisions of ASU 2016-02, Leases. When the Company cannot determine the actual implicit rate in a lease, it uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments. The Company gives consideration to its recent debt issuances, if any, as well as publicly available data for instruments with similar characteristics when calculating its incremental borrowing rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company's lease term includes any option to extend the lease when it is reasonably certain to be exercised based on considering all relevant economic factors. Operating expense charges from the lessor are accounted for on an accrual basis. The Company has elected not to separate the lease and non-lease components. The leases have remaining initial terms ranging from less than 1 year to 5 years . The Company reviews the carrying value of its right-of-use assets for impairment whenever events or changes in circumstances indicate that the recorded value may not be recoverable. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If the Company determines that an impairment exists, any related impairment loss is estimated based on fair values.
Recent Accounting Pronouncements Issued and Adopted and Recent Accounting Pronouncements Issued and Not Yet Adopted	ASC 842, Leases : In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), as subsequently amended, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors), and replaces the existing guidance in ASC 840, Leases . The new standard also requires lessees to recognize operating and finance lease liabilities and corresponding ROU assets on the balance sheet and to provide enhanced disclosures surrounding the amount, timing and uncertainty of cash flows arising from leasing arrangements. On January 1, 2022, the Company adopted ASC 842 using the modified retrospective method. The Company has presented financial results and applied its accounting policies for the period beginning January 1, 2022 under ASC 842, while prior period results and accounting policies have not been adjusted and are reflected under legacy GAAP pursuant to ASC 840. In connection with the adoption of ASC 842, the Company performed an analysis of contracts under ASC 840 to ensure proper assessment of leases (or embedded leases) in existence as of January 1, 2022. The Company elected the package of practical expedients permitted under ASC 842, which allows the Company not to reassess 1) whether any expired or existing contracts as of the adoption date are or contain a lease, 2) lease classification for any expired or existing leases as of the adoption date and 3) initial direct costs for any existing leases as of the adoption date. The most significant impact of applying ASC 842 was the recognition of ROU asset and lease liabilities for operating leases in its condensed consolidated balance sheets. On January 1, 2022, the Company recognized an initial operating ROU asset of $7.7 million and associated operating lease liab ilities of $7.7 million . Refer to Note 6 — Leases for further information regarding the impact of the adoption of ASU 2016-02 on the Company's financial statements, as well as its various accounting policies for each lease type. Recent Accounting Pronouncements Issued and not yet Adopted: ASU 2016-13, Financial Instruments — Credit Losses (“ASU 2016-13”): In June 2016, the FASB issued ASU 2016-13, which states the Company will be required to use an expected-loss model for its marketable debt securities, available-for sale, which requires that credit losses be presented as an allowance rather than as an impairment write-down. Reversals of credit losses (in situations in which the estimate of credit losses declines) is permitted in the reporting period that the change occurs. Current U.S. GAAP prohibits reflecting reversals of credit losses in current period earnings. At June 30, 2022 , the Company had $77.9 million in marketable debt securities, available for sale which would be subject to this new standard. As of December 31, 2021, these marketable debt securities, available for sale have an average credit rating of A and no impairment write-downs have been recorded. The Company is currently evaluating the impact of this new standard on its investment policy and investments and does not expect the standard to have a material impact on its financial statements at adoption or in subsequent periods. The Company expects to adopt the new standard effective January 1, 2023 .

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	The following tables reflect the impact of the restatement adjustments to the specific line items presented in our previously issued unaudited financial statements for the periods indicated (in thousands, except per share amounts): June 30, 2022 Condensed Consolidated Balance Sheets As Previously Reported Adjustments As Restated Inventories $ 62,197 $ (3,955) $ 58,242 Prepaid expenses and other current assets 20,971 (3,173) 17,798 Total current assets 168,035 (7,128) 160,907 Total assets 206,817 (7,128) 199,689 Accounts payable 8,761 (342) 8,419 Other current liabilities 21,767 (3,763) 18,004 Total current liabilities 30,528 (4,105) 26,423 Total liabilities 57,387 (4,105) 53,282 Accumulated deficit (34,746) (3,023) (37,769) Total stockholders' equity 149,430 (3,023) 146,407 Total liabilities and stockholders' equity $ 206,817 $ (7,128) $ 199,689 Three Months Ended June 30, 2022 Condensed Consolidated Statement of Operations and Comprehensive Loss As Previously Reported Adjustments Restated Cost of goods sold $ 14,891 $ 179 $ 15,070 Gross loss (5,125) (179) (5,304) Loss from operations (27,813) (179) (27,992) Loss before provision from income taxes (9,466) (179) (9,645) Net loss (9,467) (179) (9,646) Total comprehensive loss $ (9,617) $ (179) $ (9,796) Net loss per share Basic $ (0.06) $ — $ (0.06) Diluted $ (0.06) $ — $ (0.06) Six Months Ended June 30, 2022 Condensed Consolidated Statement of Operations and Comprehensive Loss As Previously Reported Adjustments Restated Cost of goods sold $ 25,077 $ 3,023 $ 28,100 Gross loss (8,280) (3,023) (11,303) Loss from operations (51,267) (3,023) (54,290) Loss before provision from income taxes (30,650) (3,023) (33,673) Net loss (30,653) (3,023) (33,676) Total comprehensive loss $ (31,629) $ (3,023) $ (34,652) Net loss per share Basic $ (0.19) $ (0.02) $ (0.21) Diluted $ (0.19) $ (0.02) $ (0.21) Six Months Ended June 30, 2022 Condensed Consolidated Statement of Legacy Xos Preferred Stock and Stockholders' Equity (Deficit) As Previously Reported Adjustments As Restated Net and comprehensive loss $ (31,629) $ (3,023) $ (34,652) Accumulated Deficit $ (34,746) $ (3,023) $ (37,769) Total Stockholders' Equity (Deficit) $ 149,430 $ (3,023) $ 146,407 Six Months Ended June 30, 2022 Condensed Consolidated Statement of Cash Flows As Previously Reported Adjustments Restated Net loss $ (30,653) $ (3,023) $ (33,676) Inventory reserves $ 2,212 $ (221) $ 1,991 Changes in operating assets and liabilities: Inventories $ (33,058) $ 4,176 $ (28,882) Prepaid expenses and other current assets $ (3,121) $ 3,173 $ 52 Accounts payable $ (2,102) $ (343) $ (2,445) Other liabilities $ 17,126 $ (3,762) $ 13,364
Schedule of Product Warranty Liability	The reconciliation of the change in the Company’s product liability balances during the three months and six months ended June 30, 2022 consisted of the following (in thousands) : Three Months Ended June 30, 2022 Six Months Ended June 30, 2022 Warranty liability, beginning of period $ 475 $ 177 Reduction in liability (payments) (6) (6) Increase in liability (new warranties) 363 661 Warranty liability, end of period $ 832 $ 832

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Disaggregated revenues by major source during the three and six months ended June 30, 2022 and 2021 consisted of the following ( in thousands ): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Product and service revenue Stepvans & vehicle incentives $ 8,561 $ — $ 15,424 $ 715 Powertrains 656 596 670 674 Fleet-as-a-Service 38 — 133 — Total product revenue 9,255 596 16,227 1,389 Ancillary revenue 511 — 570 — Total revenues $ 9,766 $ 596 $ 16,797 $ 1,389

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory amounted to $58.2 million and $30.9 million, respectively, as of June 30, 2022 and December 31, 2021 and consisted of the following (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Raw materials $ 35,381 $ 20,382 Work in process 25,911 10,659 Finished goods — 901 Inventories, gross of reserves 61,292 31,942 Less: inventory reserve (3,050) (1,059) Inventories $ 58,242 $ 30,883

Selected Balance Sheet Data (Ta

Selected Balance Sheet Data (Tables)	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets as of June 30, 2022 and December 31, 2021 consisted of the following ( in thousands ): June 30, 2022 (As restated) (1) December 31, 2021 Prepaid inventories $ 12,562 $ 7,303 Prepaid insurance 1,102 4,996 Deposits (primarily relating to deposits on equipment purchases) 805 2,783 Assets held for sale 1,848 1,848 Prepaid licenses and subscriptions 741 801 Others 740 119 Total $ 17,798 $ 17,850
Schedule of Other Current Liabilities	Other current liabilities as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Accrued expenses and other (2) $ 12,583 $ 4,303 Lease liabilities, current 3,520 482 Customer deposits 1,068 899 Warranty liability 833 177 Total $ 18,004 $ 5,861 ____________ (1) For discussion on the restatement adjustments, see Note 2 – Basis of Presentation and Summary of Significant Accounting Policies – Restatement of Unaudited Condensed Consolidated Financial Statements. (2) Primarily relates to accrued inventory purchases, personnel costs — wages, health benefits, vacation and other accruals.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Schedule of Lease, Cost	A summary of the balances relating to the Company’s lease assets and liabilities as of June 30, 2022 consisted of the following (in thousands) : Balance Sheet Location June 30, 2022 Assets Operating leases Operating lease right-of-use assets, net $ 7,306 Equipment finance leases Property and equipment, net 7,734 Total Lease Assets $ 15,040 Liabilities Current Operating leases Other current liabilities $ 1,484 Equipment finance leases Other current liabilities 2,036 Sub-total $ 3,520 Non-current Operating leases Other non-current liabilities $ 5,950 Equipment finance leases Other non-current liabilities 4,788 Sub-total $ 10,738 Total Lease Liabilities $ 14,258 (in thousands) : Three Months Ended June 30, Six Months Ended June 30, Income Statement Location 2022 2021 2022 2021 Amortization General and administrative expense $ 78 $ 19 $ 238 $ 48 Interest accretion on finance lease liabilities Other income (expense), net 65 4 92 10 Total $ 143 $ 23 $ 330 $ 58
Schedule of Supplemental Cash Flow Information, Weighted-Average Remaining Lease Term and Discount Rate	The weighted-average remaining lease term and discount rates, as well as supplemental cash flow information as of and for the six months ended June 30, 2022 consisted of the following ( in thousands for the supplemental cashflow information ): Supplemental cashflow information: Cash paid for amounts included in the measurement of operating lease liabilities $ 808 ROU assets obtained in exchange for operating lease obligations $ 437 Weighted average remaining lease term: Operating leases 4.4 years Equipment finance leases 3.1 years Weighted average discount rate: Operating lease - IBR 5.5 % Equipment finance leases - rate implicit in the lease 7.8 %
Operating Leases, Maturity Analysis Under Topic 842	A summary of the undiscounted cash flows and a reconciliation to the Company’s lease liabilities as of June 30, 2022 consisted of the following (in thousands) : June 30, 2022 Operating Leases Equipment Finance Leases Total 2022 (remaining six months) $ 926 $ 1,311 $ 2,237 2023 1,860 2,408 4,268 2024 1,907 2,329 4,236 2025 1,963 1,224 3,187 2026 1,631 360 1,991 Thereafter 114 29 143 Total future minimum lease payments $ 8,401 $ 7,661 $ 16,062 Less: imputed interest 967 837 1,804 Present value of Lease Liabilities $ 7,434 $ 6,824 $ 14,258
Finance Lease, Liability, Maturity Analysis Under Topic 842	A summary of the undiscounted cash flows and a reconciliation to the Company’s lease liabilities as of June 30, 2022 consisted of the following (in thousands) : June 30, 2022 Operating Leases Equipment Finance Leases Total 2022 (remaining six months) $ 926 $ 1,311 $ 2,237 2023 1,860 2,408 4,268 2024 1,907 2,329 4,236 2025 1,963 1,224 3,187 2026 1,631 360 1,991 Thereafter 114 29 143 Total future minimum lease payments $ 8,401 $ 7,661 $ 16,062 Less: imputed interest 967 837 1,804 Present value of Lease Liabilities $ 7,434 $ 6,824 $ 14,258
Schedule of Future Minimum Lease Payments for Capital Leases	Schedule of future minimum lease payments for operating and finance leases as of December 31, 2021 consisted of the following (in thousands) : December 31, 2021 Operating Leases Equipment Finance Leases Total 2022 $ 1,167 $ 482 $ 1,649 2023 1,158 442 1,600 2024 1,192 386 1,578 2025 1,228 401 1,629 2026 1,265 339 1,604 Thereafter 106 27 133 Total future minimum lease payments $ 6,116 $ 2,077 $ 8,193
Schedule of Future Minimum Rental Payments for Operating Leases	Schedule of future minimum lease payments for operating and finance leases as of December 31, 2021 consisted of the following (in thousands) : December 31, 2021 Operating Leases Equipment Finance Leases Total 2022 $ 1,167 $ 482 $ 1,649 2023 1,158 442 1,600 2024 1,192 386 1,578 2025 1,228 401 1,629 2026 1,265 339 1,604 Thereafter 106 27 133 Total future minimum lease payments $ 6,116 $ 2,077 $ 8,193

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost, Gross Unrealized Gains/Losses In Accumulated Other Comprehensive Loss And Fair Value Of Marketable Debt Securities, Available-For-Sale	Amortized cost, gross unrealized gains/losses in accumulated other comprehensive loss and fair value of marketable debt securities, available-for-sale, by type of security as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Short-term investments: Corporate debt security $ 42,945 $ — $ (695) $ 42,250 U.S. treasuries 5,608 — (74) 5,534 Asset-backed security and other 5,868 — (77) 5,791 Non-U.S. government and supranational bonds 9,179 — (107) 9,072 Certificate of deposit 2,004 — — 2,004 $ 65,604 $ — $ (953) $ 64,651 Long-term investments: Corporate debt security $ 11,580 $ — $ (349) $ 11,231 Asset-backed security and other 2,042 — (55) 1,987 $ 13,622 $ — $ (404) $ 13,218 December 31, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Short-term investments: Corporate debt security $ 71,406 $ — $ (57) $ 71,349 U.S. treasuries 3,415 — (7) 3,408 Asset-backed security and other 2,555 — (4) 2,551 Non-U.S. government and supranational bonds 16,405 1 (19) 16,387 Certificate of deposit 1,001 — — 1,001 $ 94,782 $ 1 $ (87) $ 94,696 Long-term investments: Corporate debt security $ 42,703 $ — $ (246) $ 42,457 U.S. treasuries 2,201 — (5) 2,196 Asset-backed security and other 5,438 — (28) 5,410 Non-U.S. government and supranational bonds 3,769 — (16) 3,753 Certificate of deposit 1,000 — — 1,000 $ 55,111 $ — $ (295) $ 54,816
Schedule of Marketable Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The Company’s investments in marketable debt securities, available-for-sale that have been in a continuous unrealized loss position by type of security as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Less than 12 months 12 months or greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Corporate debt security $ 53,481 $ (1,044) $ — $ — $ 53,481 $ (1,044) US treasuries 5,534 (74) — — 5,534 (74) Asset-backed security and other 7,778 (132) — — 7,778 (132) Non-U.S. government and supranational bonds 9,072 (107) — — 9,072 (107) Certificates of deposit 2,004 — — — 2,004 — $ 77,869 $ (1,357) $ — $ — $ 77,869 $ (1,357) December 31, 2021 Less than 12 months 12 months or greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Corporate debt security $ 113,806 $ (303) $ — $ — $ 113,806 $ (303) US treasuries 5,604 (12) — — 5,604 (12) Asset-backed security and other 7,961 (32) — — 7,961 (32) Non-U.S. government and supranational bonds 20,140 (34) — — 20,140 (34) Certificates of deposit 2,001 — — — 2,001 — $ 149,512 $ (381) $ — $ — $ 149,512 $ (381)
Schedule of Realized Gain (Loss)	Gross realized gains and gross realized losses from the sales of the Company’s marketable debt securities, available-for-sale for the three and six months ended June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Gross realized gains $ — $ — $ — $ — Gross realized losses $ (63) $ — $ (69) $ —
Schedule of Amortized Cost And Fair Value Of Marketable Debt Securities, Available-For-Sale By Contractual Maturity	Amortized cost and fair value of marketable debt securities, available-for-sale by contractual maturity as of June 30, 2022 consisted of the following ( in thousands , except weighted average data ): Amortized Cost Fair Value Due in one year or less $ 65,604 $ 64,651 Due after one year through five years 13,622 13,218 $ 79,226 $ 77,869 Weighted average contractual maturity 0.7 years Amortized cost and fair value of marketable debt securities, available-for-sale by contractual maturity as of December 31, 2021 consisted of the following ( in thousands , except weighted average data ): Amortized Cost Fair Value Due in one year or less $ 94,782 $ 94,696 Due after one year through five years 55,111 54,816 $ 149,893 $ 149,512 Weighted average contractual maturity 0.8 years

Compensation Related Costs, Sha

Compensation Related Costs, Share Based Payments (Tables)	6 Months Ended
	Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Stock option activity	Stock option activity during the six months ended June 30, 2022 consisted of the following: Options Weighted Average Fair Value Weighted Average Exercise Price Weighted Average Remaining Years Intrinsic Value December 31, 2021 — Options outstanding 1,838,759 $ 0.02 $ 0.02 8.22 $ 5,756,797 Granted — — — Exercised 400 0.02 0.02 Forfeited 3,678 0.03 0.02 March 31, 2022 — Options outstanding 1,834,681 $ 0.02 $ 0.02 7.98 $ 5,450,514 Granted — — — Exercised 38,693 0.02 0.04 Forfeited 9,309 0.02 0.03 June 30, 2022 — Options outstanding 1,786,679 $ 0.02 $ 0.02 7.69 $ 3,253,977 June 30, 2022 — Options vested and exercisable 767,020 $ 0.02 $ 0.02 7.48 $ 1,396,965
Restricted Stock Units (RSUs) Activity	RSU activity during the six months ended June 30, 2022 consisted of the following: RSUs Weighted Average Grant Date Fair Value Weighted Average Fair Value December 31, 2021 — RSU outstanding 1,844,820 $ 3.60 $ 5,811,183 Granted 1,618,442 2.67 3,960,984 Vested 133,349 3.21 347,382 Forfeited 117,532 3.38 279,746 March 31, 2022 — RSU outstanding 3,212,381 $ 3.27 $ 9,605,019 Granted 724,299 2.51 1,818,247 Vested 88,730 3.48 228,923 Forfeited 208,375 3.14 530,965 June 30, 2022 — RSU outstanding 3,639,575 $ 3.12 $ 6,696,818
Schedule of recognized stock-based compensation expense in the consolidated statements of operations and comprehensive income (loss)	The Company’s recognized stock-based compensation expense (including earn-out RSUs) in the condensed consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2022, and 2021 consisted of the following ( in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of goods sold $ 198 $ — $ 227 $ — Research and development 93 — 354 — Sales and marketing 36 — 94 — General and administrative 751 1 1,794 3 Total $ 1,078 $ 1 $ 2,469 $ 3

Property and Equipment, net (Ta

Property and Equipment, net (Tables)	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property and equipment, net consisted of the following at June 30, 2022 and December 31, 2021 (in thousands) : June 30, 2022 (As restated) (1) December 31, 2021 Equipment $ 8,985 $ 5,244 Furniture & fixtures 168 141 Company vehicles 629 153 Leasehold improvements 626 626 Computers, software and related equipment 1,762 1,289 Construction in progress 6,930 1,444 Property and Equipment, gross 19,100 8,897 Accumulated depreciation (2,346) (1,471) Property and Equipment, net $ 16,754 $ 7,426

Net Loss per Share (Tables)

Net Loss per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss per Share	Basic and diluted net loss per share during the three and six months ended June 30, 2022 and 2021 consisted of the following ( in thousands , except per share amounts ): Three Months Ended June 30, Six Months Ended June 30, 2022 (As restated) (1) 2021 2022 (As restated) (1) 2021 Numerator: Net income (loss) $ (9,646) $ (9,158) $ (33,676) $ (23,008) Denominator: Basic Weighted average common shares outstanding — basic 164,041 72,389 163,606 72,372 Basic net loss per share $ (0.06) $ (0.13) $ (0.21) $ (0.32) Diluted Weighted average common shares outstanding from above 164,041 72,389 163,606 72,372 Add: dilutive effect of options — — — — Add: dilutive effect of RSUs — — — — Weighted average common shares outstanding 164,041 72,389 163,606 72,372 Diluted net loss per share $ (0.06) $ (0.13) $ (0.21) $ (0.32)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potential weighted average shares that were excluded from the computation of diluted net income (loss) per share because their effect was anti-dilutive as of June 30, 2022 and 2021 consisted of the following (in thousands) : Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contingent earn-out shares 16,422 — 16,422 — Common stock public and private warrants 18,833 — 18,833 — Restricted stock units 708 — 717 — Stock options 1,783 2,339 1,798 2,390

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Assets measured at fair value of a recurring basis	Assets and liabilities carried at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 2,207 $ 2,207 $ — $ — $ 2,207 $ 2,207 $ — $ — Short-Term Investments: U.S. treasuries $ 5,534 $ 5,534 $ — $ — Corporate debt security 42,250 — 42,250 — Asset-backed security and other 5,791 — 5,791 — Non-U.S. government and supranational bonds 9,072 — 9,072 — Certificate of Deposit 2,004 — 2,004 — $ 64,651 $ 5,534 $ 59,117 $ — Long-Term Investments: Corporate debt security $ 11,231 $ — $ 11,231 $ — Asset-backed security and other 1,987 — 1,987 — $ 13,218 $ — $ 13,218 $ — Total Financial Assets $ 80,076 $ 7,741 $ 72,335 $ — Financial Liabilities: Private Placement Warrants $ 49 $ — $ 49 $ — Public Warrants 4,178 4,178 — — Contingent Earn-out Shares liability 11,894 — — 11,894 Total Financial Liabilities $ 16,121 $ 4,178 $ 49 $ 11,894 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets. December 31, 2021 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 5,868 $ 5,868 $ — $ — Non-U.S. government and supranational bonds 647 — 647 — Corporate debt security 1,805 — 1,805 — $ 8,320 $ 5,868 $ 2,452 $ — Short-Term Investments: U.S. treasuries $ 3,408 $ 3,408 $ — $ — Corporate debt security 71,349 — 71,349 — Asset-backed security and other 2,551 — 2,551 — Non-U.S. government and supranational bonds 16,387 — 16,387 — Certificate of Deposit 1,001 — 1,001 — $ 94,696 $ 3,408 $ 91,288 $ — Long-Term Investments: U.S. treasuries $ 2,196 $ 2,196 $ — $ — Corporate debt security 42,457 — 42,457 — Asset-backed security and other 5,410 — 5,410 — Non-U.S. government and supranational bonds 3,753 — 3,753 — Certificate of Deposit 1,000 — 1,000 — $ 54,816 $ 2,196 $ 52,620 $ — Total Financial Assets $ 157,832 $ 11,472 $ 146,360 $ — Financial Liabilities: Private Placement Warrants $ 140 $ — $ 140 $ — Public Warrants 7,356 7,356 — — Contingent Earn-out Shares liability 29,240 — — 29,240 Total Financial Liabilities $ 36,736 $ 7,356 $ 140 $ 29,240 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets.
Liabilities measured at fair value of a recurring basis	Assets and liabilities carried at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands) : June 30, 2022 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 2,207 $ 2,207 $ — $ — $ 2,207 $ 2,207 $ — $ — Short-Term Investments: U.S. treasuries $ 5,534 $ 5,534 $ — $ — Corporate debt security 42,250 — 42,250 — Asset-backed security and other 5,791 — 5,791 — Non-U.S. government and supranational bonds 9,072 — 9,072 — Certificate of Deposit 2,004 — 2,004 — $ 64,651 $ 5,534 $ 59,117 $ — Long-Term Investments: Corporate debt security $ 11,231 $ — $ 11,231 $ — Asset-backed security and other 1,987 — 1,987 — $ 13,218 $ — $ 13,218 $ — Total Financial Assets $ 80,076 $ 7,741 $ 72,335 $ — Financial Liabilities: Private Placement Warrants $ 49 $ — $ 49 $ — Public Warrants 4,178 4,178 — — Contingent Earn-out Shares liability 11,894 — — 11,894 Total Financial Liabilities $ 16,121 $ 4,178 $ 49 $ 11,894 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets. December 31, 2021 Fair Value Level 1 Level 2 Level 3 Financial Assets Cash and Cash Equivalents (1) : Money market funds $ 5,868 $ 5,868 $ — $ — Non-U.S. government and supranational bonds 647 — 647 — Corporate debt security 1,805 — 1,805 — $ 8,320 $ 5,868 $ 2,452 $ — Short-Term Investments: U.S. treasuries $ 3,408 $ 3,408 $ — $ — Corporate debt security 71,349 — 71,349 — Asset-backed security and other 2,551 — 2,551 — Non-U.S. government and supranational bonds 16,387 — 16,387 — Certificate of Deposit 1,001 — 1,001 — $ 94,696 $ 3,408 $ 91,288 $ — Long-Term Investments: U.S. treasuries $ 2,196 $ 2,196 $ — $ — Corporate debt security 42,457 — 42,457 — Asset-backed security and other 5,410 — 5,410 — Non-U.S. government and supranational bonds 3,753 — 3,753 — Certificate of Deposit 1,000 — 1,000 — $ 54,816 $ 2,196 $ 52,620 $ — Total Financial Assets $ 157,832 $ 11,472 $ 146,360 $ — Financial Liabilities: Private Placement Warrants $ 140 $ — $ 140 $ — Public Warrants 7,356 7,356 — — Contingent Earn-out Shares liability 29,240 — — 29,240 Total Financial Liabilities $ 36,736 $ 7,356 $ 140 $ 29,240 ____________ (1) Included in total cash and cash equivalents in the condensed consolidated balance sheets.
Schedule of Changes on Fair Value of Financial Liabilities	The changes in the fair value of Level 3 financial liabilities during the three six months ended June 30, 2022 consisted of the following (in thousands): Three months ended June 30, 2022 Six months ended June 30, 2022 Fair value, beginning of period $ 26,938 $ 29,240 Recognition of earn-out RSUs (174) 148 Change in fair value during the period (14,870) (17,494) Fair value, end of period $ 11,894 $ 11,894
Fair Value Measurement Inputs and Valuation Techniques	Significant unobservable inputs related to Level 3 earn-out shares liability consisted of the following as of June 30, 2022: June 30, 2022 Stock price $1.84 Stock price volatility 80.0% Expected term 4.14 years Risk-free interest rate 3.0%

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Mar. 31, 2022	Jun. 30, 2021
Property, Plant and Equipment [Line Items]
Reduction in liability (payments)	$ 6,000	$ 6,000	$ 0
Warranty liability	832,000	832,000	177,000	$ 475,000	$ 0
Operating lease right-of-use assets, net	7,306,000	7,306,000	0
Operating lease liabilities	7,434,000	7,434,000
Accounting Standards Update 2016-13
Property, Plant and Equipment [Line Items]
Debt securities, available-for-sale	$ 77,900,000	77,900,000
Other-than-temporary impairment loss, debt securities, available-for-sale		$ 0
Cumulative Effect, Period of Adoption, Adjustment
Property, Plant and Equipment [Line Items]
Operating lease right-of-use assets, net			7,700,000
Operating lease liabilities			$ 7,700,000
Minimum
Property, Plant and Equipment [Line Items]
Standard product warranty, period of warranty		2 years
Remaining lease term	1 year	1 year
Maximum
Property, Plant and Equipment [Line Items]
Standard product warranty, period of warranty		5 years
Remaining lease term	5 years	5 years

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Impact of the Restatement Adjustments (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Inventories	$ 58,242				$ 58,242		$ 30,883
Prepaid expenses and other current assets	17,798				17,798		17,850
Total current assets	160,907				160,907		165,958
Total assets	199,689				199,689		228,706
Accounts payable	8,419				8,419		10,122
Other current liabilities	18,004				18,004		5,861
Total current liabilities	26,423				26,423		15,983
Total liabilities	53,282				53,282		54,313
Accumulated deficit	(37,769)				(37,769)		(4,093)
Total stockholders' equity	146,407	$ 150,570	$ (49,820)	$ (40,663)	146,407	$ (49,820)	174,393	$ (27,197)
Total liabilities and stockholders' equity	199,689				199,689		228,706
Income Statement [Abstract]
Cost of goods sold	15,070		585		28,100	1,257
Gross loss	(5,304)		11		(11,303)	132
Loss from operations	(27,992)		(7,854)		(54,290)	(13,398)
Loss before provision from income taxes	(9,645)		(9,158)		(33,673)	(23,008)
Net loss	(9,646)		(9,158)	(13,850)	(33,676)	(23,008)
Total comprehensive loss	$ (9,796)	(24,856)	$ (9,158)		$ (34,652)	$ (23,008)
Net loss per share
Net loss per share — basic (in dollar per share)	$ (0.06)		$ (0.13)		$ (0.21)	$ (0.32)
Net loss per share — diluted (in dollar per share)	$ (0.06)		$ (0.13)		$ (0.21)	$ (0.32)
Statement of Cash Flows [Abstract]
Inventory reserve					$ 1,991	$ 0
Inventories					(28,882)	(4,941)
Prepaid expenses and other current assets					52	(1,697)
Accounts payable					(2,445)	(581)
Other liabilities					13,364	564
Accumulated Deficit (As restated)
Statement of Financial Position [Abstract]
Total stockholders' equity	$ (37,769)	(28,123)	$ (50,502)	(41,344)	(37,769)	$ (50,502)	$ (4,093)	$ (27,494)
Income Statement [Abstract]
Net loss			$ (9,158)	$ (13,850)
Total comprehensive loss	(9,646)	$ (24,030)
As Previously Reported
Statement of Financial Position [Abstract]
Inventories	62,197				62,197
Prepaid expenses and other current assets	20,971				20,971
Total current assets	168,035				168,035
Total assets	206,817				206,817
Accounts payable	8,761				8,761
Other current liabilities	21,767				21,767
Total current liabilities	30,528				30,528
Total liabilities	57,387				57,387
Accumulated deficit	(34,746)				(34,746)
Total stockholders' equity	149,430				149,430
Total liabilities and stockholders' equity	206,817				206,817
Income Statement [Abstract]
Cost of goods sold	14,891				25,077
Gross loss	(5,125)				(8,280)
Loss from operations	(27,813)				(51,267)
Loss before provision from income taxes	(9,466)				(30,650)
Net loss	(9,467)				(30,653)
Total comprehensive loss	$ (9,617)				$ (31,629)
Net loss per share
Net loss per share — basic (in dollar per share)	$ (0.06)				$ (0.19)
Net loss per share — diluted (in dollar per share)	$ (0.06)				$ (0.19)
Statement of Cash Flows [Abstract]
Inventory reserve					$ 2,212
Inventories					(33,058)
Prepaid expenses and other current assets					(3,121)
Accounts payable					(2,102)
Other liabilities					17,126
As Previously Reported | Accumulated Deficit (As restated)
Statement of Financial Position [Abstract]
Total stockholders' equity	$ (34,746)				(34,746)
Restatement Adjustments
Statement of Financial Position [Abstract]
Inventories	(3,955)				(3,955)
Prepaid expenses and other current assets	(3,173)				(3,173)
Total current assets	(7,128)				(7,128)
Total assets	(7,128)				(7,128)
Accounts payable	(342)				(342)
Other current liabilities	(3,763)				(3,763)
Total current liabilities	(4,105)				(4,105)
Total liabilities	(4,105)				(4,105)
Accumulated deficit	(3,023)				(3,023)
Total stockholders' equity	(3,023)				(3,023)
Total liabilities and stockholders' equity	(7,128)				(7,128)
Income Statement [Abstract]
Cost of goods sold	179				3,023
Gross loss	(179)				(3,023)
Loss from operations	(179)				(3,023)
Loss before provision from income taxes	(179)				(3,023)
Net loss	(179)				(3,023)
Total comprehensive loss	$ (179)				$ (3,023)
Net loss per share
Net loss per share — basic (in dollar per share)	$ 0				$ (0.02)
Net loss per share — diluted (in dollar per share)	$ 0				$ (0.02)
Statement of Cash Flows [Abstract]
Inventory reserve					$ (221)
Inventories					4,176
Prepaid expenses and other current assets					3,173
Accounts payable					(343)
Other liabilities					(3,762)
Restatement Adjustments | Accumulated Deficit (As restated)
Statement of Financial Position [Abstract]
Total stockholders' equity	$ (3,023)				$ (3,023)

Basis of Presentation, Summary

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Warrant Liability (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Movement in Extended Product Warranty Accrual [Roll Forward]
Warranty liability, beginning of period	$ 475	$ 177
Reduction in liability (payments)	(6)	(6)	$ 0
Increase in liability (new warranties)	363	661
Warranty liability, end of period	$ 832	$ 832	$ 177

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregated Revenues by Major Source (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Ancillary revenue	$ 511	$ 0	$ 570	$ 0
Revenues	9,766	596	16,797	1,389
Product and service revenue
Disaggregation of Revenue [Line Items]
Revenues	9,255	596	16,227	1,389
Stepvans & vehicle incentives
Disaggregation of Revenue [Line Items]
Revenues	8,561	0	15,424	715
Powertrains
Disaggregation of Revenue [Line Items]
Revenues	656	596	670	674
Fleet-as-a-Service
Disaggregation of Revenue [Line Items]
Revenues	$ 38	$ 0	$ 133	$ 0

Inventories - Narrative (Detail

Inventories - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	$ 58,242	$ 30,883

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 35,381	$ 20,382
Work in process	25,911	10,659
Finished goods	0	901
Inventories, gross of reserves	61,292	31,942
Less: inventory reserve	(3,050)	(1,059)
Inventories	$ 58,242	$ 30,883

Selected Balance Sheet Data - P

Selected Balance Sheet Data - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid inventories	$ 12,562	$ 7,303
Prepaid insurance	1,102	4,996
Deposits (primarily relating to deposits on equipment purchases)	805	2,783
Assets held for sale	1,848	1,848
Prepaid licenses and subscriptions	741	801
Others	740	119
Total	$ 17,798	$ 17,850

Selected Balance Sheet Data - O

Selected Balance Sheet Data - Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses and other	$ 12,583	$ 4,303
Lease liabilities, current	3,520	482
Customer deposits	1,068	899
Warranty liability	833	177
Total	$ 18,004	$ 5,861

Leases - Lease Assets and Liabi

Leases - Lease Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease right-of-use assets, net	$ 7,306	$ 0
Equipment finance leases	7,734
Total Lease Assets	$ 15,040
Finance lease, right-of-use asset, statement of financial position [extensible enumeration]	Property and equipment, net
Current
Operating leases	$ 1,484
Equipment finance leases	2,036
Sub-total	$ 3,520	$ 482
Operating lease, liability, current, statement of financial position [extensible enumeration]	Other current liabilities
Finance lease, liability, current, statement of financial position [extensible enumeration]	Other current liabilities
Non-current
Operating leases	$ 5,950
Equipment finance leases	4,788
Sub-total	$ 10,738
Operating lease, liability, noncurrent, statement of financial position [extensible enumeration]	Other non-current liabilities
Finance lease, liability, noncurrent, statement of financial position [extensible enumeration]	Other non-current liabilities
Total Lease Liabilities	$ 14,258

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases [Abstract]
Operating lease, term of contract	5 years		5 years
Rent expense	$ 0.4		$ 0.9
Operating leases, rent expense, net		$ 0.1		$ 0.3
Short-term lease expense	$ 0.3		$ 0.4

Leases - Finance Lease Cost (De

Leases - Finance Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases [Abstract]
Amortization	$ 78	$ 19	$ 238	$ 48
Interest accretion on finance lease liabilities	65	4	92	10
Total	$ 143	$ 23	$ 330	$ 58

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Supplemental cashflow information:
Cash paid for amounts included in the measurement of operating lease liabilities	$ 808
ROU assets obtained in exchange for operating lease obligations	$ 437	$ 0
Weighted average remaining lease term:
Real estate operating lease, weighted average remaining lease term	4 years 4 months 24 days
Equipment finance leases, weighted average remaining lease term	3 years 1 month 6 days
Weighted average discount rate:
Real estate operating lease - IBR, weighted average discount rate, percent	5.50%
Equipment finance leases - rate implicit in the lease, weighted average discount rate, percent	7.80%

Leases - Future Lease Liability

Leases - Future Lease Liability Payments Under Topic 842 (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Operating Leases
2022 (remaining six months)	$ 926
2023	1,860
2024	1,907
2025	1,963
2026	1,631
Thereafter	114
Total future minimum lease payments	8,401
Less: imputed interest	967
Present value of Lease Liabilities	7,434
Equipment Finance Leases
2022 (remaining six months)	1,311
2023	2,408
2024	2,329
2025	1,224
2026	360
Thereafter	29
Total future minimum lease payments	7,661
Less: imputed interest	837
Present value of Lease Liabilities	6,824
2022 (remaining six months)	2,237
2023	4,268
2024	4,236
2025	3,187
2026	1,991
Thereafter	143
Total future minimum lease payments	16,062
Less: imputed interest	1,804
Present value of Lease Liabilities	$ 14,258

Leases - Future Lease Liabili_2

Leases - Future Lease Liability Payments Under Topic 840 (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Operating Leases
2022	$ 1,167
2023	1,158
2024	1,192
2025	1,228
2026	1,265
Thereafter	106
Total future minimum lease payments	6,116
Equipment Finance Leases
2022	482
2023	442
2024	386
2025	401
2026	339
Thereafter	27
Total future minimum lease payments	2,077
2022	1,649
2023	1,600
2024	1,578
2025	1,629
2026	1,604
Thereafter	133
Total future minimum lease payments	$ 8,193

Recapitalization and Continge_2

Recapitalization and Contingent Earn-out Shares Liability - Narrative (Details) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended
	Aug. 20, 2021 USD ($) boardOfDirector day $ / shares shares	Jun. 30, 2022 USD ($) shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) shares	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Schedule Of Recapitalization [Line Items]
Board of directors, maximum authorized members | boardOfDirector	9
Number of Board of director members | boardOfDirector	6
Recapitalization exchange ratio	1.956440
Stock issued during period, shares, reverse recapitalization (in shares) | shares	142,584,621
Sale of stock, number of shares issued in transaction (in shares) | shares	19,600,000
Sale of stock, price per share (in dollars per share) | $ / shares	$ 10
Sale of stock, consideration received on transaction | $	$ 196,000
Committed amount | $	4,000
Payments of reverse recapitalization transaction costs | $	44,200
Earn-out shares liability | $	101,700	$ 11,894		$ 11,894		$ 29,240
Warrants liabilitites | $	$ 17,900
Derivative instrument, contingent consideration, liability, shares (in shares) | shares	16,200,000
Change in fair value of earn-out shares liability | $		$ 14,870	$ 0	$ 17,494	$ 0
Derivative Instrument, Tranche One
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, shares (in shares) | shares	5,400,000
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 14
Threshold trading days | day	10
Threshold trading day period | day	20
Earnout period	5 years
Derivative Instrument, Tranche One | Minimum
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 14
Derivative Instrument, Tranche One | Maximum
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 20
Derivative Instrument, Tranche Two
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, shares (in shares) | shares	5,400,000
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 20
Threshold trading days | day	10
Threshold trading day period | day	20
Derivative Instrument, Tranche Two | Minimum
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 20
Derivative Instrument, Tranche Two | Maximum
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 25
Derivative Instrument, Tranche Three
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, shares (in shares) | shares	5,400,000
Derivative instrument, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 25
Threshold trading days | day	10
Threshold trading day period | day	20
Restricted Stock Units (RSUs)
Schedule Of Recapitalization [Line Items]
Derivative instrument, contingent consideration, liability, shares (in shares) | shares	261,000
Founders
Schedule Of Recapitalization [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares	2,000,000
Sale of stock, price per share (in dollars per share) | $ / shares	$ 10
Sale of stock, consideration received on transaction | $	$ 20,000
Public Warrants
Schedule Of Recapitalization [Line Items]
Number of warrants issued (in shares) | shares	12,499,964	18,613,299		18,613,299
Warrants liabilitites | $		$ 4,200		$ 4,200
Private Placement Warrants
Schedule Of Recapitalization [Line Items]
Number of warrants issued (in shares) | shares	6,333,334	219,999		219,999
Warrants liabilitites | $		$ 49		$ 49
NextGen
Schedule Of Recapitalization [Line Items]
Payments of stock issuance costs | $	$ 11,200

Investments - Amortized Cost, G

Investments - Amortized Cost, Gross Unrealized Gains/Losses In Accumulated Other Comprehensive Loss And Fair Value Of Marketable Debt Securities, Available-For-Sale (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Short-term investments:
Amortized Cost	$ 65,604	$ 94,782
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(953)	(87)
Marketable debt securities, available-for-sale — short-term	64,651	94,696
Long-term investments:
Amortized Cost	13,622	55,111
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(404)	(295)
Marketable debt securities, available-for-sale — long-term	13,218	54,816
Corporate debt security
Short-term investments:
Amortized Cost	42,945	71,406
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(695)	(57)
Marketable debt securities, available-for-sale — short-term	42,250	71,349
Long-term investments:
Amortized Cost	11,580	42,703
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(349)	(246)
Marketable debt securities, available-for-sale — long-term	11,231	42,457
U.S. treasuries
Short-term investments:
Amortized Cost	5,608	3,415
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(74)	(7)
Marketable debt securities, available-for-sale — short-term	5,534	3,408
Long-term investments:
Amortized Cost		2,201
Gross Unrealized Gains		0
Gross Unrealized Losses		(5)
Marketable debt securities, available-for-sale — long-term		2,196
Asset-backed security and other
Short-term investments:
Amortized Cost	5,868	2,555
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(77)	(4)
Marketable debt securities, available-for-sale — short-term	5,791	2,551
Long-term investments:
Amortized Cost	2,042	5,438
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(55)	(28)
Marketable debt securities, available-for-sale — long-term	1,987	5,410
Non-U.S. government and supranational bonds
Short-term investments:
Amortized Cost	9,179	16,405
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(107)	(19)
Marketable debt securities, available-for-sale — short-term	9,072	16,387
Long-term investments:
Amortized Cost		3,769
Gross Unrealized Gains		0
Gross Unrealized Losses		(16)
Marketable debt securities, available-for-sale — long-term		3,753
Certificate of deposit
Short-term investments:
Amortized Cost	2,004	1,001
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Marketable debt securities, available-for-sale — short-term	$ 2,004	1,001
Long-term investments:
Amortized Cost		1,000
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Marketable debt securities, available-for-sale — long-term		$ 1,000

Investments - Continuous Unreal

Investments - Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	$ 77,869	$ 149,512
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	(1,357)	(381)
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	77,869	149,512
Marketable debt securities, unrealized loss position, accumulated loss	(1,357)	(381)
Corporate debt security
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	53,481	113,806
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	(1,044)	(303)
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	53,481	113,806
Marketable debt securities, unrealized loss position, accumulated loss	(1,044)	(303)
U.S. treasuries
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	5,534	5,604
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	(74)	(12)
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	5,534	5,604
Marketable debt securities, unrealized loss position, accumulated loss	(74)	(12)
Asset-backed security and other
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	7,778	7,961
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	(132)	(32)
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	7,778	7,961
Marketable debt securities, unrealized loss position, accumulated loss	(132)	(32)
Non-U.S. government and supranational bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	9,072	20,140
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	(107)	(34)
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	9,072	20,140
Marketable debt securities, unrealized loss position, accumulated loss	(107)	(34)
Certificate of deposit
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Marketable debt securities, continuous unrealized loss position, less than 12 months	2,004	2,001
Marketable debt securities, continuous unrealized loss position, less than 12 months, accumulated loss	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer	0	0
Marketable debt securities, continuous unrealized loss position, 12 months or longer, accumulated loss	0	0
Marketable debt securities, unrealized loss position	2,004	2,001
Marketable debt securities, unrealized loss position, accumulated loss	$ 0	$ 0

Investments - Gross Realized Ga

Investments - Gross Realized Gains (Losses) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Gross realized gains	$ 0	$ 0	$ 0	$ 0
Gross realized losses	$ (63)	$ 0	$ (69)	$ 0

Investments - Amortized Cost an

Investments - Amortized Cost and Fair Value of Marketable Debt Securities, Available-for-sale by Contractual Maturity (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Amortized Cost
Due in one year or less	$ 65,604	$ 94,782
Due after one year through five years	13,622	55,111
Total, amortized cost	79,226	149,893
Fair Value
Due in one year or less	64,651	94,696
Due after one year through five years	13,218	54,816
Total, fair value	$ 77,869	$ 149,512
Weighted average contractual maturity	8 months 12 days	9 months 18 days

Equity (Details)

Equity (Details) $ / shares in Units, $ in Thousands			3 Months Ended
	Mar. 23, 2022 USD ($) shares	Aug. 20, 2021 USD ($) shares	Jun. 30, 2022 USD ($) vote $ / shares shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2021 $ / shares shares
Stockholders' Equity And Temporary Equity [Line Items]
Stock authorized (in shares)			1,010,000,000
Common stock, authorized (in shares)			1,000,000,000			1,000,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001
Preferred stock, authorized (in shares)			10,000,000			10,000,000
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001
Number of votes per share | vote			1
Issuance of preferred shares (in shares)				49,518,000
Issuance of Legacy Xos Preferred Stock, including note conversion | $				$ 66,701
Sale of stock, consideration received on transaction | $		$ 196,000
Sale of stock, number of shares issued in transaction (in shares)		19,600,000
Standby Equity Purchase Agreement
Stockholders' Equity And Temporary Equity [Line Items]
Sale of stock, consideration received on transaction | $	$ 125,000		$ 4,300
Request period in force	36 months
Sale of stock, number of shares issued in transaction (in shares)	18,582		1,809,515
Remaining commitment amount available | $			$ 120,700
Legacy Xos
Stockholders' Equity And Temporary Equity [Line Items]
Legacy Xos preferred stock, authorized (in shares)					25,794,475
Issuance of preferred shares (in shares)				3,739,846	1,411,764
Number of warrants issued (in shares)					1
Conversion of interest payable on convertible notes (in shares)					319,411
Issuance of Legacy Xos Preferred Stock, including note conversion | $				$ 31,800	$ 9,600
Temporary equity, subscribed but unissued, subscriptions receivable (in shares) | $					2,400
Temporary equity, conversion of convertible securities | $					21,500
Conversion of convertible securities, accrued interest | $					$ 2,500
Temporary equity, conversion of convertible securities (in shares)					21,570,308
Reduction of fair value of non-voting shares, percentage					3%

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($) day $ / shares shares	Aug. 20, 2021 USD ($) shares
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Warrants outstanding fair value | $		$ 17,900
Threshold consecutive trading days ending on the third day prior to notice of redemption	10 days
Warrant Redemption Scenario One
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Redemption, stock price threshold (in dollars per share)	$ 18
Redemption price (in dollars per share)	$ 0.01
Redemption notice period	30 days
Redemption, threshold trading days | day	20
Redemption, threshold consecutive trading days	30 days
Redemption period	30 days
Warrant Redemption Scenario Two
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Redemption, stock price threshold (in dollars per share)	$ 10
Redemption price (in dollars per share)	$ 0.10
Redemption notice period	30 days
Reference value (in dollars per share)	$ 18
Public Warrants
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of warrants issued (in shares) | shares	18,613,299	12,499,964
Warrants outstanding fair value | $	$ 4,200
Exercise price of warrants or rights (in dollars per share)	$ 11.50
Private Placement Warrants
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of warrants issued (in shares) | shares	219,999	6,333,334
Warrants outstanding fair value | $	$ 49

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	1,786,679,000			1,786,679,000		1,838,759,000
Aggregate intrinsic value of options exercised	$ 114,000		$ 0	$ 115,000	$ 6,000
Options, granted (in shares)	0	0	0	0	0
Unamortized stock-based compensation	$ 9,300,000			$ 9,300,000
Unamortized stock-based compensation, weighted average remaining amortization period				3 years 1 month 13 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested in period, intrinsic value	$ 228,923	$ 347,382		$ 600,000
2018 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for issuance (in shares)	0			0
Options outstanding (in shares)		1,834,681,000
Expiration period				10 years
Vesting period				4 years
2021 Equity Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)	20,431,516			20,431,516
Share-based Payment Arrangement, Tranche One | 2018 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				25%
Share-based Payment Arrangement, Tranche Two | 2018 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				36 months

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options Activity (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Options
Options, outstanding beginning balance (in shares)		1,838,759,000		1,838,759,000
Options, granted (in shares)	0	0	0	0	0
Stock options exercised (in shares)	38,693,000	400,000
Options, forfeited (in shares)	9,309,000	3,678,000
Options, outstanding ending balance (in shares)	1,786,679,000			1,786,679,000		1,838,759,000
Options vested and exercisable (in shares)	767,020,000			767,020,000
Weighted Average Fair Value
Options outstanding beginning balance (in dollars per share)	$ 20	$ 20		$ 20
Options granted, weighted average grant date fair value (in dollars per share)	0	0
Options, exercised, weighted average grant date fair value (in dollars per share)	20	20
Options, forfeited in period, weighted average grant date fair value (in dollars per share)	20	30
Options outstanding ending balance (in dollars per share)	0.02	20		0.02		$ 20
Options, vested and exercisable, weighted average grant date fair value (in dollars per share)				0.02
Weighted Average Exercise Price
Options, outstanding, beginning balance, weighted average exercise price (in dollars per share)	20	20		20
Options, granted, weighted average exercise price (in dollars per share)	0	0
Options, exercised, weighted average exercise price (in dollars per share)	40	20
Options, forfeited, weighted average exercise price (in dollars per share)	30	20
Options, outstanding, ending balance, weighted average exercise price (in dollars per share)	0.02	$ 20		0.02		$ 20
Options, exercisable, weighted average exercise price (in dollars per share)	$ 0.02			$ 0.02
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term	7 years 8 months 8 days	7 years 11 months 23 days				8 years 2 months 19 days
Options, exercisable, weighted average remaining contractual term				7 years 5 months 23 days
Options outstanding, intrinsic value	$ 3,253,977	$ 5,450,514		$ 3,253,977		$ 5,756,797
Options, exercisable, intrinsic value	$ 1,396,965			$ 1,396,965

Stock-Based Compensation - RSU

Stock-Based Compensation - RSU Activity (Details) - Restricted Stock Units (RSUs) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022
RSU’s
Beginning balance, outstanding (in shares)	3,212,381	1,844,820	1,844,820
Granted in period (in shares)	724,299	1,618,442
Vested in period (in shares)	88,730	133,349
Forfeited in period (in shares)	208,375	117,532
Ending balance, outstanding (in shares)	3,639,575	3,212,381	3,639,575
Weighted Average Grant Date Fair Value
Beginning balance, outstanding (in dollars per share)	$ 3,270	$ 3,600	$ 3,600
Granted in period (in dollars per share)	2,510	2,670
Vested in period (in dollars per share)	3,480	3,210
Forfeitures (in dollars per share)	3,140	3,380
Ending balance, outstanding (in dollars per share)	$ 3,120	$ 3,270	$ 3,120
Weighted Average Fair Value
Beginning balance	$ 9,605,019	$ 5,811,183	$ 5,811,183
Granted	1,818,247	3,960,984
Vested	228,923	347,382	600,000
Forfeited	530,965	279,746
Ending balance	$ 6,696,818	$ 9,605,019	$ 6,696,818

Stock-Based Compensation - Reco

Stock-Based Compensation - Recognized Stock-based Compensation Expense Activity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 1,078	$ 1	$ 2,469	$ 3
Cost of goods sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	198	0	227	0
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	93	0	354	0
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	36	0	94	0
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 751	$ 1	$ 1,794	$ 3

Property and Equipment, net (De

Property and Equipment, net (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 19,100	$ 8,897
Accumulated depreciation	(2,346)	(1,471)
Property and Equipment, net	16,754	7,426
Equipment
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	8,985	5,244
Furniture & fixtures
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	168	141
Company vehicles
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	629	153
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	626	626
Computers, software and related equipment
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	1,762	1,289
Construction in progress
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 6,930	$ 1,444

Property and Equipment, net - N

Property and Equipment, net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation	$ 300	$ 300	$ 562	$ 380

Related Party Transactions (Det

Related Party Transactions (Details)	3 Months Ended			6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($) note_payable	Jun. 30, 2021 USD ($)
Related Party Transaction [Line Items]
Related party transaction, expenses from transactions with related party	$ 35,000	$ 35,000		$ 70,000	$ 70,000
Notes payable, related parties	$ 364,000			$ 364,000
Notes payable, related parties, interest rate, stated percentage	2.38%			2.38%
Notes payable, related parties, accrued interest			$ 15,000
Notes payable, related parties, number of notes payable converted | note_payable				34
Temporary equity, conversion of convertible securities	$ 18,900,000			$ 18,900,000
Temporary equity, conversion of convertible securities (in shares)	19,664,000			19,664,000
Increase in employee related liabilities	0	37,000		0	74,000
Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, expenses from transactions with related party	$ 189,000	$ 0		$ 361,000	$ 0

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate, percent	(0.01%)	0%	(0.01%)	0%

Net Loss per Share - Computatio

Net Loss per Share - Computation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net loss	$ (9,646)	$ (9,158)	$ (13,850)	$ (33,676)	$ (23,008)
Denominator:
Weighted average shares outstanding — basic (in shares)	164,041	72,389		163,606	72,372
Net loss per share — basic (in dollar per share)	$ (0.06)	$ (0.13)		$ (0.21)	$ (0.32)
Dilutive effect
Weighted average shares outstanding — diluted (in shares)	164,041	72,389		163,606	72,372
Net loss per share — diluted (in dollar per share)	$ (0.06)	$ (0.13)		$ (0.21)	$ (0.32)
Options
Dilutive effect
Add: dilutive effect of share-based payment arrangements	0	0		0	0
Restricted Stock Units (RSUs)
Dilutive effect
Add: dilutive effect of share-based payment arrangements	0	0		0	0

Net Loss per Share - Potential

Net Loss per Share - Potential Weighted Average Shares That Were Excluded From The Computation Of Diluted Net Income (Loss) Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Contingent earn-out shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares that were excluded from the computation of diluted net loss per share (in shares)	16,422	0	16,422	0
Common stock public and private warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares that were excluded from the computation of diluted net loss per share (in shares)	18,833	0	18,833	0
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares that were excluded from the computation of diluted net loss per share (in shares)	708	0	717	0
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares that were excluded from the computation of diluted net loss per share (in shares)	1,783	2,339	1,798	2,390

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Aug. 20, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	$ 64,651	$ 94,696
Long-Term Investments	13,218	54,816
Warrants liabilitites			$ 17,900
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	49
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	4,200
U.S. treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,534	3,408
Long-Term Investments		2,196
Corporate debt security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	42,250	71,349
Long-Term Investments	11,231	42,457
Asset-backed security and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,791	2,551
Long-Term Investments	1,987	5,410
Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	2,004	1,001
Long-Term Investments		1,000
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	2,207	8,320
Short-Term Investments	64,651	94,696
Long-Term Investments	13,218	54,816
Total Financial Assets	80,076	157,832
Contingent Earn-out Shares liability	11,894	29,240
Total Financial Liabilities	16,121	36,736
Fair Value, Recurring | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	49	140
Fair Value, Recurring | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	4,178	7,356
Fair Value, Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	2,207	5,868
Fair Value, Recurring | U.S. treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,534	3,408
Long-Term Investments		2,196
Fair Value, Recurring | Corporate debt security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		1,805
Short-Term Investments	42,250	71,349
Long-Term Investments	11,231	42,457
Fair Value, Recurring | Asset-backed security and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,791	2,551
Long-Term Investments	1,987	5,410
Fair Value, Recurring | Non-U.S. government and supranational bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		647
Short-Term Investments	9,072	16,387
Long-Term Investments		3,753
Fair Value, Recurring | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	2,004	1,001
Long-Term Investments		1,000
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	2,207	5,868
Short-Term Investments	5,534	3,408
Long-Term Investments	0	2,196
Total Financial Assets	7,741	11,472
Contingent Earn-out Shares liability	0	0
Total Financial Liabilities	4,178	7,356
Fair Value, Recurring | Level 1 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	0	0
Fair Value, Recurring | Level 1 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	4,178	7,356
Fair Value, Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	2,207	5,868
Fair Value, Recurring | Level 1 | U.S. treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,534	3,408
Long-Term Investments		2,196
Fair Value, Recurring | Level 1 | Corporate debt security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0
Short-Term Investments	0	0
Long-Term Investments	0	0
Fair Value, Recurring | Level 1 | Asset-backed security and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	0	0
Long-Term Investments	0	0
Fair Value, Recurring | Level 1 | Non-U.S. government and supranational bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0
Short-Term Investments	0	0
Long-Term Investments		0
Fair Value, Recurring | Level 1 | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	0	0
Long-Term Investments		0
Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	2,452
Short-Term Investments	59,117	91,288
Long-Term Investments	13,218	52,620
Total Financial Assets	72,335	146,360
Contingent Earn-out Shares liability	0	0
Total Financial Liabilities	49	140
Fair Value, Recurring | Level 2 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	49	140
Fair Value, Recurring | Level 2 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	0	0
Fair Value, Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Fair Value, Recurring | Level 2 | U.S. treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	0	0
Long-Term Investments		0
Fair Value, Recurring | Level 2 | Corporate debt security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		1,805
Short-Term Investments	42,250	71,349
Long-Term Investments	11,231	42,457
Fair Value, Recurring | Level 2 | Asset-backed security and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	5,791	2,551
Long-Term Investments	1,987	5,410
Fair Value, Recurring | Level 2 | Non-U.S. government and supranational bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		647
Short-Term Investments	9,072	16,387
Long-Term Investments		3,753
Fair Value, Recurring | Level 2 | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	2,004	1,001
Long-Term Investments		1,000
Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	0	0
Total Financial Assets	0	0
Contingent Earn-out Shares liability	11,894	29,240
Total Financial Liabilities	11,894	29,240
Fair Value, Recurring | Level 3 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	0	0
Fair Value, Recurring | Level 3 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liabilitites	0	0
Fair Value, Recurring | Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Fair Value, Recurring | Level 3 | U.S. treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	0	0
Long-Term Investments		0
Fair Value, Recurring | Level 3 | Corporate debt security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0
Short-Term Investments	0	0
Long-Term Investments	0	0
Fair Value, Recurring | Level 3 | Asset-backed security and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	0	0
Long-Term Investments	0	0
Fair Value, Recurring | Level 3 | Non-U.S. government and supranational bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0
Short-Term Investments	0	0
Long-Term Investments		0
Fair Value, Recurring | Level 3 | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-Term Investments	$ 0	0
Long-Term Investments		$ 0

Fair Value Measurements - Chang

Fair Value Measurements - Changes in the Fair Value of the Financial Liabilities (Details) - Contingent Earn-out Shares Liability - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 26,938	$ 29,240
Recognition of earn-out RSUs	(174)	148
Change in fair value during the period	(14,870)	(17,494)
Ending Balance	$ 11,894	$ 11,894

Fair Value Measurements - Signi

Fair Value Measurements - Significant Unobservable Inputs Related To Level 3 Earn-Out Shares Liability (Details) - Level 3	Jun. 30, 2022 $ / shares yr
Measurement Input, Share Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out shares, liability, measurement input | $ / shares	1.84
Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out shares, liability, measurement input	0.800
Measurement Input, Expected Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out shares, liability, measurement input | yr	4.14
Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out shares, liability, measurement input	0.030

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - USD ($) $ / shares in Units, $ in Millions	Aug. 09, 2022	Aug. 11, 2022
Convertible Debt
Subsequent Event [Line Items]
Debt instrument, face amount	$ 35	$ 20
Interest rate, stated percentage	6%
Interest rate, upon an event of default	10%
Interest rate upon registration rights agreement	7.50%
Lowest daily VWAP, price per share (in dollars per share)	$ 2.4733
Lowest daily VWAP, percentage	97%
Floor price per share (in dollars per share)	$ 0.50
Convertible Debt | Yorkville
Subsequent Event [Line Items]
Debt instrument, face amount		$ 15
Convertible Notes Payable
Subsequent Event [Line Items]
Debt instrument, face amount	$ 20
Interest rate, stated percentage	10%
Debt instrument, option for additional amount to be exercised	$ 20
Volume weighted average price period	10 days
Conversion price (in dollars per share)	$ 2.3817

Uncategorized Items - xos-20220

Label	Element	Value
Operating Lease, Right-Of-Use Asset And Operating Lease, Liability	xos_OperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	$ 7,682,000